Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-130b-5p BMP7 0.17 0.33761 0.83 0.04887 mirMAP -0.32 0.00583 NA
2 hsa-miR-1976 BMP7 -0.43 0.00325 0.83 0.04887 MirTarget -0.45 0.00115 NA
3 hsa-miR-22-3p BMP7 -0.63 0 0.83 0.04887 miRNAWalker2 validate; miRTarBase -0.87 1.0E-5 NA
4 hsa-miR-30a-5p BMP7 -0.63 0.00011 0.83 0.04887 mirMAP; miRNATAP -0.35 0.00579 NA
5 hsa-miR-30e-5p BMP7 -0.63 0 0.83 0.04887 mirMAP -0.58 0.00444 NA
6 hsa-miR-34a-5p BMP7 1.04 0 0.83 0.04887 miRNAWalker2 validate -0.45 0.00162 NA
7 hsa-miR-616-5p BMP7 0.15 0.40284 0.83 0.04887 mirMAP -0.33 0.0036 NA
8 hsa-miR-330-3p CTNNB1 -0.33 0.03161 0 0.98356 MirTarget; PITA; miRNATAP -0.13 0 NA
9 hsa-miR-331-3p CTNNB1 -0.28 0.03738 0 0.98356 miRNAWalker2 validate -0.11 0.00027 NA
10 hsa-miR-335-5p CUL7 -1.61 0 1.13 0 miRNAWalker2 validate -0.12 2.0E-5 NA
11 hsa-miR-139-5p FAM83D -2.11 0 2.34 0 miRanda -0.4 0 NA
12 hsa-miR-142-3p FAM83D -1.42 0 2.34 0 miRanda -0.24 1.0E-5 NA
13 hsa-miR-429 FAM83D -1.4 7.0E-5 2.34 0 miRanda -0.12 7.0E-5 NA
14 hsa-miR-486-5p FAM83D -1.78 0 2.34 0 miRanda -0.12 0.00685 NA
15 hsa-miR-107 FGFR2 0.24 0.01708 -2.29 1.0E-5 PITA; miRanda -0.69 0.00689 NA
16 hsa-miR-26b-5p FOXF2 -1.11 0 1.43 0 miRNAWalker2 validate -0.55 0 NA
17 hsa-miR-3607-3p FOXF2 -2.16 0 1.43 0 miRNATAP -0.31 0 NA
18 hsa-miR-590-3p FOXF2 -0.47 2.0E-5 1.43 0 PITA; miRanda -0.4 0.00236 NA
19 hsa-miR-29b-3p GSK3B -0.35 0.01214 0.11 0.07745 miRTarBase; miRNATAP -0.11 0 NA
20 hsa-miR-342-3p GSK3B -0.32 0.04498 0.11 0.07745 miRanda -0.11 0 NA
21 hsa-miR-224-3p HGF 1.41 0 -3.46 0 mirMAP -0.25 0.00042 NA
22 hsa-miR-30d-5p HGF 0.72 0 -3.46 0 mirMAP -0.64 0 NA
23 hsa-miR-3682-3p HGF 0.81 1.0E-5 -3.46 0 mirMAP -0.32 0.00119 NA
24 hsa-miR-421 HGF 0.94 0 -3.46 0 miRanda -0.37 0.00016 NA
25 hsa-miR-616-5p HGF 0.15 0.40284 -3.46 0 mirMAP -0.33 0.00071 NA
26 hsa-miR-107 HIF1A 0.24 0.01708 -0.37 0.0111 miRNAWalker2 validate; miRTarBase; miRanda -0.44 0 NA
27 hsa-miR-17-5p HIF1A 0.7 2.0E-5 -0.37 0.0111 miRTarBase; MirTarget; TargetScan -0.21 0 NA
28 hsa-miR-20a-5p HIF1A 0.85 0 -0.37 0.0111 miRNAWalker2 validate; miRTarBase; MirTarget -0.25 0 22901144 Correlation analysis showed that the key miRNAs miR-20a and miR-20b negatively correlated with the target proteins VEGF-A and HIF-1alpha
29 hsa-miR-33a-5p HIF1A -0.77 1.0E-5 -0.37 0.0111 miRNAWalker2 validate -0.11 0.0073 NA
30 hsa-miR-616-5p HIF1A 0.15 0.40284 -0.37 0.0111 MirTarget -0.12 0.00144 NA
31 hsa-miR-660-5p HIF1A 0.99 0 -0.37 0.0111 MirTarget -0.25 0 NA
32 hsa-miR-93-5p HIF1A 1.4 0 -0.37 0.0111 MirTarget -0.17 0.00043 NA
33 hsa-let-7b-3p HMGA2 -1.22 0 1.12 0.01594 mirMAP -0.93 0 20949044; 18413822; 23073586; 21598109; 24612219; 23700794; 21412931 Since let-7 miRNAs generally play a tumor-suppressive role as targeting oncogenes such as RAS and HMGA2 our results suggest that AZ-P7a cells release let-7 miRNAs via exosomes into the extracellular environment to maintain their oncogenesis;Recent studies report that HMGA2 is negatively regulated by the let-7 microRNA miRNA family; However no studies have examined the clinical significance of HMGA2 and its relationship to the let-7 miRNA family in gastric cancer; We also did an association study comparing HMGA2 expression and let-7 miRNA family expression in gastric cancer; Furthermore our findings suggest that HMGA2 is negatively regulated by the let-7 miRNA family in human gastric cancer;HMGA2 mRNA and let-7 family microRNA were detected by real time fluorescent quantitative reverse transcription polymerase chain reaction in the corresponding frozen tissues; All let-7 family members were detectable in all ovarian cancer samples and their expression were inversely correlated with HMGA2 mRNA expression r=-0.305P<0.05; The downregulation of let-7 is but not the only mechanism of HMGA2 overexpression in serous ovarian cancer;Role of microRNA let 7 and effect to HMGA2 in esophageal squamous cell carcinoma; To investigated the role of microRNA miRNA let-7 and its regulation on high mobility group A2 HMGA2 protein expression in esophageal squamous cell carcinoma ESCC; To evaluate the role of let-7 and HMGA2 cell proliferations were analyzed with synthetic let-7 mimics- or its inhibitor-transfected cells; The transcription of let-7 inversely correlated with HMGA2 protein; The present results demonstrated that let-7 and HMGA2 involved in ESCC carcinogenesis;HMGA2 is down regulated by microRNA let 7 and associated with epithelial mesenchymal transition in oesophageal squamous cell carcinomas of Kazakhs; To investigate the expression of let-7 and its regulation of high-mobility group A2 protein HMGA2 and to verify the relationship between let-7 HMGA2 and the process of epithelial-mesenchymal transition EMT in oesophageal squamous cell carcinomas OSCC of Kazakh patients; Let-7 could repress expression of HMGA2 after co-transfection with let-7 and HMGA2 P = 0.002; Moreover let-7 expression was observed less frequently P = 2.0 × 10-8 and HMGA2 expression more frequently P = 1.0 × 10-10 in OSCC than in normal adjacent tissues; and let-7 expression was observed less frequently in OSCC from Kazakh patients than in those from Han and Uygur patients P = 0.041; There was a reverse correlation between expression of let-7 and HMGA2 P = 0.018; Expression of let-7 can suppress cell proliferation by acting directly on regulation of HMGA2 in OSCC;MiR-98 a member in the let-7 family acts as a negative regulator in the expression of HMGA2 high mobility group A2 oncogene and it has been shown to have a nearly 3-fold decrease in A549/DDP cells;Let 7 microRNA and HMGA2 levels of expression are not inversely linked in adipocytic tumors: analysis of 56 lipomas and liposarcomas with molecular cytogenetic data; The aim of our study was first to assess the role of HMGA2 expression in the pathogenesis of adipocytic tumors AT and second to seek a potential correlation between overexpression of HMGA2 and let-7 expression inhibition by analyzing a series of 56 benign and malignant AT with molecular cytogenetic data; We measured the levels of expression of HMGA2 mRNA and of eight members of the let-7 microRNA family using quantitative RT-PCR and expression of HMGA2 protein using immunohistochemistry; Although overexpression of both HMGA2 mRNA and protein in a majority of ordinary lipomas without HMGA2 structural rearrangement may have suggested a potential role for let-7 microRNAs we did not observe a significant link with let-7 inhibition in such cases
34 hsa-let-7c-5p HMGA2 -1.71 0 1.12 0.01594 miRNAWalker2 validate; miRTarBase; MirTarget -0.68 0 NA
35 hsa-let-7g-5p HMGA2 -0.46 2.0E-5 1.12 0.01594 miRNAWalker2 validate; miRTarBase; MirTarget -0.72 0.00056 21472347; 18308936 Furthermore K-Ras and HMGA2 are well known as targets of let-7g; In this study we evaluated the potential role of precursor pre-let-7g in lung cancer cell metastasis focusing on the two targets of let-7g HMGA2 and K-Ras;In let-7g expressing tumors reductions in Ras family and HMGA2 protein levels were detected; Ectopic expression of K-RasG12D largely rescued let-7g mediated tumor suppression whereas ectopic expression of HMGA2 was less effective
36 hsa-miR-125b-2-3p HMGA2 -1.66 0 1.12 0.01594 mirMAP -0.57 0 NA
37 hsa-miR-125b-5p HMGA2 -1.36 0 1.12 0.01594 miRNAWalker2 validate; miRTarBase -0.77 0 NA
38 hsa-miR-148a-5p HMGA2 -0.77 0 1.12 0.01594 mirMAP -0.66 0 NA
39 hsa-miR-195-3p HMGA2 -1.09 0 1.12 0.01594 mirMAP -0.52 2.0E-5 NA
40 hsa-miR-195-5p HMGA2 -1.86 0 1.12 0.01594 MirTarget -0.67 0 NA
41 hsa-miR-30a-3p HMGA2 -1.53 0 1.12 0.01594 MirTarget -0.45 0.0002 NA
42 hsa-miR-30a-5p HMGA2 -0.63 0.00011 1.12 0.01594 mirMAP -0.46 0.00103 NA
43 hsa-miR-30e-3p HMGA2 -1.21 0 1.12 0.01594 MirTarget -0.77 3.0E-5 NA
44 hsa-miR-30e-5p HMGA2 -0.63 0 1.12 0.01594 mirMAP -0.8 0.00035 NA
45 hsa-miR-33b-5p HMGA2 -2.29 0 1.12 0.01594 MirTarget -0.4 1.0E-5 27609581; 25868853; 25725129 The expression and significance of miR 33b and HMGA2 in esophageal squamous cell carcinoma; Objective To investigate the expression and significance of miR-33b and high mobility group AT-hook 2 HMGA2 in esophageal squamous cell carcinoma ESCC; Methods Real-time quantitative PCR qRT-PCR was used to detect the expression levels of miR-33b and HMGA2 mRNA from the ESCC and adjacent tissues; After the miR-33b mimics inhibitor and controls were separately transfected into TE-1 and Eca-109 cells the expression levels of miR-33b and HMGA2 in each group were again determined by qRT-PCR and Western blotting; The expression level of miR-33b in the HMGA2 positive group was lower than that in the HMGA2 negative group; The correlation analysis showed that the expression of miR-33b was negatively correlated with the mRNA expression of HMGA2 in the ESCC tissues; There were no significant difference in the mRNA expression of HMGA2 among the cells transfected separately with miR-33b mimics inhibitor and controls but Western blotting indicated that the protein expression of HMGA2 decreased significantly in the miR-33b over-expressed cells; Conclusion The expression of miR-33b decreases and HMGA2 increases in the ESCC tissues;By targeting HMGA2 and Twist1 miR-33b attenuated melanoma migration and invasiveness upon cordycepin exposure;MicroRNA 33b upregulated by EF24 a curcumin analog suppresses the epithelial to mesenchymal transition EMT and migratory potential of melanoma cells by targeting HMGA2; miR-33b directly bound to HMGA2 3' untranslated region 3'-UTR to suppress its expression as measured by dual-luciferase assay; Thus the results suggest that EF24 suppresses melanoma metastasis via upregulating miR-33b and concomitantly reducing HMGA2 expression
46 hsa-miR-34a-5p HMGA2 1.04 0 1.12 0.01594 miRNAWalker2 validate -0.54 0.00061 18803879 miR-34 targets Notch HMGA2 and Bcl-2 genes involved in the self-renewal and survival of cancer stem cells; Human gastric cancer Kato III cells with miR-34 restoration reduced the expression of target genes Bcl-2 Notch and HMGA2; The mechanism of miR-34-mediated suppression of self-renewal appears to be related to the direct modulation of downstream targets Bcl-2 Notch and HMGA2 indicating that miR-34 may be involved in gastric cancer stem cell self-renewal/differentiation decision-making
47 hsa-miR-3607-3p HMGA2 -2.16 0 1.12 0.01594 mirMAP -0.31 0.0019 NA
48 hsa-miR-497-5p HMGA2 -1.41 0 1.12 0.01594 MirTarget -0.76 0 NA
49 hsa-let-7a-3p LEF1 -0.57 0 2.66 0 miRNATAP -0.64 4.0E-5 NA
50 hsa-let-7b-3p LEF1 -1.22 0 2.66 0 miRNATAP -0.67 0 NA
51 hsa-miR-193b-3p LEF1 -0.17 0.27202 2.66 0 miRNAWalker2 validate -0.53 0 NA
52 hsa-miR-217 LEF1 1.06 0.0401 2.66 0 miRanda -0.11 0.00127 NA
53 hsa-miR-26a-5p LEF1 -0.96 0 2.66 0 miRNATAP -0.92 0 NA
54 hsa-miR-26b-5p LEF1 -1.11 0 2.66 0 miRNATAP -0.88 0 24785257 miR26b is downregulated in several cancers and tumors and miR26b directly targets the lymphoid enhancer factor 1 Lef13'UTR and inhibits endogenous Lef1 expression; We report that miR26b expression is associated with human colon cancer through the regulation of LEF1 expression in colon cancer cells; Analyses of multiple colon cancer cell lines revealed an inverse correlation between miR26b and LEF1 expression; Normal human colon cells express low levels of LEF1 and high levels of miR26b; however human colon cancer cells have decreased miR26b expression and increased LEF1 expression; We demonstrate that miR26b expression is a potent inhibitor of colon cancer cell proliferation and significantly decreases LEF1 expression; Analyses of human colon cancer databases also demonstrated a link between miR26b and LEF1 expression
55 hsa-miR-3065-3p LEF1 -1.04 5.0E-5 2.66 0 miRNATAP -0.27 3.0E-5 NA
56 hsa-miR-326 LEF1 -1.88 0 2.66 0 miRanda -0.39 0 NA
57 hsa-miR-33a-3p LEF1 -0.68 1.0E-5 2.66 0 miRNATAP -0.44 5.0E-5 NA
58 hsa-miR-455-5p LEF1 -0.27 0.05813 2.66 0 miRanda -0.35 0.00298 NA
59 hsa-miR-590-3p LEF1 -0.47 2.0E-5 2.66 0 PITA; miRanda; mirMAP -0.43 0.00459 NA
60 hsa-miR-7-1-3p LEF1 -0.57 2.0E-5 2.66 0 mirMAP -0.45 0.00035 NA
61 hsa-miR-193a-3p LIMS1 -0.12 0.30939 -0.53 0.0186 MirTarget; miRanda -0.27 0.00565 NA
62 hsa-miR-30d-5p LIMS1 0.72 0 -0.53 0.0186 MirTarget -0.23 0.00702 NA
63 hsa-miR-192-5p LOXL2 -0.5 0.00345 1.64 0 miRNAWalker2 validate -0.41 0 NA
64 hsa-miR-28-5p LOXL2 -0.43 0 1.64 0 miRanda -0.41 0 NA
65 hsa-miR-455-5p LOXL3 -0.27 0.05813 0.01 0.9467 miRanda -0.25 1.0E-5 NA
66 hsa-miR-101-3p NOTCH1 -1.48 0 -0.03 0.79556 MirTarget -0.13 0.00575 NA
67 hsa-miR-34a-5p NOTCH1 1.04 0 -0.03 0.79556 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.24 0 22438124; 23140286; 24349627; 24565525; 25783790; 20351093; 27082152; 23642368; 22347519; 23430952; 23902763; 21743299; 22992310; 23145211; 25623761; 23085450 Delta tocotrienol suppresses Notch 1 pathway by upregulating miR 34a in nonsmall cell lung cancer cells; In our study using miRNA microarray we observed that downregulation of the Notch-1 pathway by delta-tocotrienol correlated with upregulation of miR-34a in nonsmall cell lung cancer cells NSCLC;We found that Re-expression forced expression of miR-34a inhibits cell growth and induces apoptosis with concomitant down-regulation of Notch-1 signaling pathway one of the target of miR-34a; Moreover treatment of PC cells with a natural compound genistein led to the up-regulation of miR-34a resulting in the down-regulation of Notch-1 which was correlated with inhibition of cell growth and induction of apoptosis;Most importantly BR-DIM intervention in PCa patients prior to radical prostatectomy showed reexpression of miR-34a which was consistent with decreased expression of AR PSA and Notch-1 in PCa tissue specimens;In addition intracellular restoration of miR-34a inhibited breast cancer cell migration via targeting Notch-1 signaling;MicroRNA 34a suppresses the breast cancer stem cell like characteristics by downregulating Notch1 pathway; In this study we verified that miR-34a directly and functionally targeted Notch1 in MCF-7 cells; We reported that miR-34a negatively regulated cell proliferation migration and invasion and breast cancer stem cell propagation by downregulating Notch1; The expression of miR-34a was negatively correlated with tumor stages metastasis and Notch1 expression in breast cancer tissues; Furthermore overexpression of miR-34a increased chemosensitivity of breast cancer cells to paclitaxel PTX by downregulating the Notch1 pathway; Taken together our results indicate that miR-34a inhibited breast cancer stemness and increased the chemosensitivity to PTX partially by downregulating the Notch1 pathway suggesting that miR-34a/Notch1 play an important role in regulating breast cancer stem cells;MicroRNA 34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells; Computational miRNA target prediction suggested that Notch1 and Jagged1 were targets of miR-34a; By using functional assays miR-34a was demonstrated to bind to the 3' untranslated regions of Notch1 and Jagged1; Forced expression of miR-34a altered the expression of Notch1 and Jagged1 protein as well as Notch signaling as shown by the response of Hairy Enhancer of Split-1 protein to these treatments using western blot analysis;We showed that miR-34a as a tumor suppressor could separately reduce the stemness of BCSCs and activate the cytotoxic susceptibility of BCSCs to natural killer NK cells in vitro via down regulating the expression of Notch1 signaling molecules;Mechanistically miR-34a sequesters Notch1 mRNA to generate a sharp threshold response where a bimodal Notch signal specifies the choice between self-renewal and differentiation;Most importantly BR-DIM intervention in PCa patients prior to radical prostatectomy showed re-expression of miR-34a which was consistent with decreased expression of AR PSA and Notch-1 in PCa tissue specimens;We also found that reexpression of miR-34a and miR-200b by transfection led to reduced expression of Notch-1 resulting in the inhibition of osteosarcoma cell proliferation invasion and angiogenesis;Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial mesenchymal transition EMT by miR 34a mediated suppression of Notch 1 expression in non small cell lung cancer cell lines; Indeed rhamnetin and cirsiliol increased the expression of tumor-suppressive microRNA miR-34a in a p53-dependent manner leading to inhibition of Notch-1 expression;MicroRNA 34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme; Also we identified notch1 as a direct target gene of miR-34a; Knockdown of notch1 showed similar cellular functions as overexpression of miR-34a both in vitro and in vivo; Collectively our findings show that miR-34a is downregulated in GBM cells and inhibits GBM growth by targeting notch1;The re-expression of miR-34 led to a marked reduction in the expression of its target gene Notch-1;Inactivation of AR and Notch 1 signaling by miR 34a attenuates prostate cancer aggressiveness; We found that over-expression of miR-34a led to reduced expression of AR PSA and Notch-1; These findings suggest that the loss of miR-34a is directly linked with up-regulation of AR and Notch-1 both of which are highly expressed in PCa and thus finding innovative approaches by which miR-34a expression could be up-regulated will have a huge impact on the treatment of PCa especially for the treatment of mCRPC;miR 34a may regulate sensitivity of breast cancer cells to adriamycin via targeting Notch1; To explore the influence of miR-34a on Notch1 expression in breast cancer cells and to explore the role of miR-34a in the sensitivity of breast cancer cells to Adriamycin ADR; The expression levels of Notch1 mRNA and protein in MCF-7/ADR cells transfected with miR-34a mimics were significantly up-regulated; On the contrary the expressions of Notch1 mRNA and protein in MCF-7 cells transfected with miR-34a inhibitor were down-regulated; miR-34a negatively regulates the expression of Notch1 at both mRNA and protein levels;MicroRNA 34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1; The association of miR-34a and Notch1 was analyzed by dual-luciferase reporter assay and Notch1-siRNA technology; Real-time PCR assay was performed to test the expression of miR-34a and Notch1 in 38 selective breast cancer tissue samples; MiR-34a mimic could inhibit the luciferase activity of the construct containing wild-type 3' UTR of Notch1 in MCF-7/ADR cells; Further there was an inverse association between Notch1 and miR-34a expression in breast cancer; Dysregulation of miR-34a plays critical roles in the acquired ADR resistance of breast cancer at least in part via targeting Notch1
68 hsa-miR-576-5p RBPJ -0.38 0.00471 0.08 0.47404 mirMAP -0.16 2.0E-5 NA
69 hsa-miR-616-5p RBPJ 0.15 0.40284 0.08 0.47404 MirTarget -0.14 0 NA
70 hsa-miR-664a-3p RBPJ 0.49 0.00073 0.08 0.47404 mirMAP -0.15 1.0E-5 NA
71 hsa-miR-204-5p SNAI1 -0.54 0.03309 -1.12 0 miRNAWalker2 validate -0.17 0.00017 26729198 miR 204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer; By building the epithelial-mesenchymal transition EMT model in vitro through the addition of transforming growth factor beta 1 TGF-β1 expressions of miR-204 and snai1 in the EMT model together with their respective effects on EMT were evaluated; The over-expression of miR-204 or downregulation of snai1 could significantly inhibit the metastasis and invasion of GC cells both in vitro and in vivo; The upregulated miR-204 expression or inhibited snai1 expression could suppress the EMT process in EMT in vitro models; Our study provided evidence that miR-204 may suppress the metastasis and invasion of GC cells through the regulation of the EMT process by targeting snai1
72 hsa-miR-148b-3p SNAI2 0.27 0.00185 0.38 0.10293 miRNAWalker2 validate -0.54 5.0E-5 NA
73 hsa-miR-181a-5p SNAI2 0.25 0.05519 0.38 0.10293 miRNAWalker2 validate -0.26 0.00311 NA
74 hsa-miR-182-5p SNAI2 1.97 0 0.38 0.10293 miRNAWalker2 validate; miRNATAP -0.1 0.00197 NA
75 hsa-miR-200b-3p SNAI2 -1.29 0.00027 0.38 0.10293 TargetScan -0.11 0.00037 NA
76 hsa-miR-200c-3p SNAI2 -0.1 0.71696 0.38 0.10293 miRNATAP -0.13 0.00081 NA
77 hsa-miR-320a SNAI2 0.33 0.02214 0.38 0.10293 miRanda -0.21 0.00813 NA
78 hsa-miR-320b SNAI2 0.09 0.60798 0.38 0.10293 miRanda -0.2 0.00173 NA
79 hsa-miR-330-3p SNAI2 -0.33 0.03161 0.38 0.10293 PITA -0.2 0.00987 NA
80 hsa-miR-335-3p SNAI2 -0.28 0.10663 0.38 0.10293 mirMAP -0.22 0.00125 NA
81 hsa-miR-375 SNAI2 -1.93 0 0.38 0.10293 miRanda -0.21 0 NA
82 hsa-miR-429 SNAI2 -1.4 7.0E-5 0.38 0.10293 PITA; miRanda; miRNATAP -0.12 0.00013 NA
83 hsa-miR-101-3p SOX9 -1.48 0 0.46 0.17811 miRNAWalker2 validate; miRNATAP -0.92 0 23178713 Ectopic expression of miR-101 significantly inhibited HCC cell proliferation and tumorigenicity by targeting SOX9; Therefore miR-101 may suppress HCC tumor progression by down-regulating SOX9
84 hsa-miR-30e-5p SOX9 -0.63 0 0.46 0.17811 MirTarget -0.79 0 NA
85 hsa-miR-616-5p SOX9 0.15 0.40284 0.46 0.17811 mirMAP; miRNATAP -0.34 0.0002 NA
86 hsa-miR-139-5p TGFB1 -2.11 0 0.08 0.68861 miRanda -0.17 0.00036 NA
87 hsa-miR-101-5p TGFB2 -1.06 0 0.53 0.03673 mirMAP -0.35 0.00011 NA
88 hsa-miR-107 TGFB2 0.24 0.01708 0.53 0.03673 miRanda -0.61 0 NA
89 hsa-miR-148a-3p TGFB2 -0.75 0 0.53 0.03673 MirTarget; miRNATAP -0.66 0 NA
90 hsa-miR-193a-3p TGFB2 -0.12 0.30939 0.53 0.03673 MirTarget; miRanda; miRNATAP -0.37 0.00066 NA
91 hsa-miR-193b-3p TGFB2 -0.17 0.27202 0.53 0.03673 MirTarget; miRNATAP -0.32 9.0E-5 NA
92 hsa-miR-33a-3p TGFB2 -0.68 1.0E-5 0.53 0.03673 MirTarget; mirMAP -0.29 0.00022 NA
93 hsa-miR-362-3p TGFB2 0.81 0 0.53 0.03673 miRanda -0.24 0.0087 NA
94 hsa-miR-548b-3p TGFB2 -0.02 0.93082 0.53 0.03673 MirTarget -0.25 0 NA
95 hsa-miR-616-5p TGFB2 0.15 0.40284 0.53 0.03673 mirMAP -0.37 0 NA
96 hsa-miR-618 TGFB2 0.14 0.51715 0.53 0.03673 MirTarget; miRNATAP -0.32 0 NA
97 hsa-let-7d-5p TGFBR3 0.05 0.70258 -1.53 0 MirTarget -0.2 0.0084 NA
98 hsa-miR-103a-3p TGFBR3 0.77 0 -1.53 0 MirTarget; miRNATAP -0.52 0 NA
99 hsa-miR-181a-5p TGFBR3 0.25 0.05519 -1.53 0 miRNAWalker2 validate; mirMAP; miRNATAP -0.39 0 NA
100 hsa-miR-181b-5p TGFBR3 0.49 0.00105 -1.53 0 mirMAP -0.47 0 NA
101 hsa-miR-181c-5p TGFBR3 -0.01 0.96913 -1.53 0 mirMAP; miRNATAP -0.22 0.00025 NA
102 hsa-miR-182-5p TGFBR3 1.97 0 -1.53 0 miRNATAP -0.18 0 NA
103 hsa-miR-18a-5p TGFBR3 0.92 2.0E-5 -1.53 0 MirTarget -0.36 0 NA
104 hsa-miR-21-5p TGFBR3 1.51 0 -1.53 0 miRNAWalker2 validate -0.7 0 NA
105 hsa-miR-222-5p TGFBR3 0.13 0.48742 -1.53 0 MirTarget -0.33 0 NA
106 hsa-miR-30d-5p TGFBR3 0.72 0 -1.53 0 mirMAP -0.34 0 NA
107 hsa-miR-335-3p TGFBR3 -0.28 0.10663 -1.53 0 mirMAP -0.16 0.00559 NA
108 hsa-miR-338-3p TGFBR3 0.54 0.00461 -1.53 0 miRanda -0.28 0 NA
109 hsa-miR-339-5p TGFBR3 0.28 0.03557 -1.53 0 miRanda -0.33 1.0E-5 NA
110 hsa-miR-423-5p TGFBR3 0.7 0 -1.53 0 MirTarget -0.37 8.0E-5 NA
111 hsa-miR-429 TGFBR3 -1.4 7.0E-5 -1.53 0 miRanda -0.13 0 NA
112 hsa-miR-501-3p TGFBR3 1 0 -1.53 0 TargetScan; miRNATAP -0.39 0 NA
113 hsa-miR-589-3p TGFBR3 1.17 0 -1.53 0 MirTarget -0.33 0 NA
114 hsa-let-7b-5p TRIM28 -0.96 0 0.65 0 miRNAWalker2 validate -0.16 0 NA
115 hsa-miR-193b-3p TRIM28 -0.17 0.27202 0.65 0 miRNAWalker2 validate -0.1 0.00123 NA
116 hsa-miR-30a-5p TRIM28 -0.63 0.00011 0.65 0 miRNAWalker2 validate -0.14 0 NA
117 hsa-miR-505-3p TRIM28 -1.2 0 0.65 0 miRNAWalker2 validate -0.14 0 NA
118 hsa-miR-505-5p TRIM28 -0.77 1.0E-5 0.65 0 miRNAWalker2 validate -0.11 2.0E-5 NA
119 hsa-miR-542-3p TRIM28 -1.31 0 0.65 0 miRanda -0.14 4.0E-5 NA
120 hsa-miR-107 WNT4 0.24 0.01708 -0.4 0.36379 PITA; miRNATAP -1.2 0 NA
121 hsa-miR-375 WNT5A -1.93 0 -0.38 0.26597 miRNATAP -0.11 0.00325 NA
NumGOOverlapSizeP ValueAdj. P Value
1 EPITHELIAL TO MESENCHYMAL TRANSITION 25 56 2.616e-67 1.217e-63
2 MESENCHYMAL CELL DIFFERENTIATION 25 134 4.176e-56 9.715e-53
3 MESENCHYME DEVELOPMENT 25 190 5.399e-52 6.281e-49
4 STEM CELL DIFFERENTIATION 25 190 5.399e-52 6.281e-49
5 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 25 513 9.453e-41 8.797e-38
6 CELLULAR COMPONENT MORPHOGENESIS 25 900 1.551e-34 1.203e-31
7 CELL DEVELOPMENT 25 1426 1.745e-29 1.16e-26
8 TISSUE DEVELOPMENT 25 1518 8.439e-29 4.908e-26
9 TISSUE MORPHOGENESIS 18 533 1.401e-23 7.245e-21
10 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 20 1142 4.679e-21 2.177e-18
11 REGULATION OF OSSIFICATION 13 178 6.68e-21 2.826e-18
12 POSITIVE REGULATION OF CELL DIFFERENTIATION 18 823 3.502e-20 1.358e-17
13 MORPHOGENESIS OF AN EPITHELIUM 15 400 6.88e-20 2.462e-17
14 MESENCHYME MORPHOGENESIS 9 38 2.316e-19 7.696e-17
15 NEGATIVE REGULATION OF GENE EXPRESSION 20 1493 9.474e-19 2.593e-16
16 REGULATION OF CELL DIFFERENTIATION 20 1492 9.349e-19 2.593e-16
17 RESPONSE TO GROWTH FACTOR 15 475 9.118e-19 2.593e-16
18 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 18 1021 1.643e-18 4.247e-16
19 ORGAN MORPHOGENESIS 17 841 2.706e-18 6.627e-16
20 GLAND DEVELOPMENT 14 395 4e-18 9.305e-16
21 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 17 957 2.372e-17 5.255e-15
22 REGULATION OF ORGAN MORPHOGENESIS 12 242 3.39e-17 7.17e-15
23 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 19 1517 5.364e-17 1.085e-14
24 REGULATION OF STEM CELL DIFFERENTIATION 10 113 6.718e-17 1.302e-14
25 CELL PROLIFERATION 15 672 1.612e-16 3.001e-14
26 EMBRYONIC ORGAN DEVELOPMENT 13 406 3.427e-16 6.132e-14
27 REPRODUCTIVE SYSTEM DEVELOPMENT 13 408 3.652e-16 6.294e-14
28 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 17 1152 5.263e-16 8.745e-14
29 POSITIVE REGULATION OF GENE EXPRESSION 19 1733 6.385e-16 1.024e-13
30 EPITHELIUM DEVELOPMENT 16 945 7.466e-16 1.158e-13
31 REGULATION OF STEM CELL PROLIFERATION 9 88 7.829e-16 1.175e-13
32 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 8 50 8.872e-16 1.29e-13
33 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 8 53 1.461e-15 2e-13
34 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 14 602 1.419e-15 2e-13
35 POSITIVE REGULATION OF CELL DEVELOPMENT 13 472 2.404e-15 3.195e-13
36 REGULATION OF CELL DEVELOPMENT 15 836 4.064e-15 5.253e-13
37 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 18 1672 9.929e-15 1.249e-12
38 EMBRYO DEVELOPMENT 15 894 1.089e-14 1.334e-12
39 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 17 1395 1.262e-14 1.505e-12
40 EMBRYONIC MORPHOGENESIS 13 539 1.327e-14 1.543e-12
41 REGULATION OF EPITHELIAL CELL PROLIFERATION 11 285 1.515e-14 1.72e-12
42 CONNECTIVE TISSUE DEVELOPMENT 10 194 1.682e-14 1.864e-12
43 TUBE DEVELOPMENT 13 552 1.801e-14 1.949e-12
44 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 9 131 3.14e-14 3.247e-12
45 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 18 1784 3.081e-14 3.247e-12
46 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 18 1805 3.779e-14 3.822e-12
47 REGULATION OF CELL PROLIFERATION 17 1496 4.001e-14 3.961e-12
48 HEART MORPHOGENESIS 10 212 4.118e-14 3.992e-12
49 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 15 983 4.377e-14 4.157e-12
50 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 15 1004 5.962e-14 5.264e-12
51 TUBE MORPHOGENESIS 11 323 5.995e-14 5.264e-12
52 CARDIOVASCULAR SYSTEM DEVELOPMENT 14 788 5.778e-14 5.264e-12
53 CIRCULATORY SYSTEM DEVELOPMENT 14 788 5.778e-14 5.264e-12
54 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 15 1008 6.319e-14 5.445e-12
55 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 14 801 7.229e-14 6.116e-12
56 CARTILAGE DEVELOPMENT 9 147 9.034e-14 7.506e-12
57 CELL MOTILITY 14 835 1.277e-13 1.024e-11
58 LOCALIZATION OF CELL 14 835 1.277e-13 1.024e-11
59 ENDOCARDIAL CUSHION MORPHOGENESIS 6 22 1.468e-13 1.158e-11
60 SENSORY ORGAN DEVELOPMENT 12 493 1.714e-13 1.329e-11
61 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 16 1360 2.184e-13 1.646e-11
62 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 9 162 2.194e-13 1.646e-11
63 GLAND MORPHOGENESIS 8 97 2.305e-13 1.677e-11
64 NEGATIVE REGULATION OF CELL DEATH 14 872 2.307e-13 1.677e-11
65 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 6 24 2.645e-13 1.893e-11
66 LOCOMOTION 15 1114 2.714e-13 1.914e-11
67 MORPHOGENESIS OF A BRANCHING STRUCTURE 9 167 2.893e-13 2.009e-11
68 NEGATIVE REGULATION OF CELL COMMUNICATION 15 1192 7.253e-13 4.963e-11
69 REGULATION OF CELL DEATH 16 1472 7.413e-13 4.999e-11
70 POSITIVE REGULATION OF STEM CELL PROLIFERATION 7 61 7.922e-13 5.266e-11
71 REGULATION OF HEART MORPHOGENESIS 6 29 9.295e-13 6.092e-11
72 REGULATION OF CARTILAGE DEVELOPMENT 7 63 1.003e-12 6.482e-11
73 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 17 1848 1.28e-12 8.048e-11
74 REGULATION OF CELLULAR COMPONENT MOVEMENT 13 771 1.274e-12 8.048e-11
75 ENDOCARDIAL CUSHION DEVELOPMENT 6 32 1.769e-12 1.097e-10
76 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 15 1275 1.921e-12 1.176e-10
77 NEGATIVE REGULATION OF CELL DIFFERENTIATION 12 609 2.067e-12 1.249e-10
78 SKIN EPIDERMIS DEVELOPMENT 7 71 2.396e-12 1.401e-10
79 REGULATION OF REPRODUCTIVE PROCESS 8 129 2.372e-12 1.401e-10
80 SKIN DEVELOPMENT 9 211 2.408e-12 1.401e-10
81 REPRODUCTION 15 1297 2.46e-12 1.413e-10
82 SKELETAL SYSTEM DEVELOPMENT 11 455 2.507e-12 1.418e-10
83 POSITIVE REGULATION OF CELL PROLIFERATION 13 814 2.53e-12 1.418e-10
84 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 6 34 2.621e-12 1.452e-10
85 REGULATION OF CELL ADHESION 12 629 3.02e-12 1.653e-10
86 HEART DEVELOPMENT 11 466 3.247e-12 1.757e-10
87 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 10 337 4.22e-12 2.257e-10
88 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 9 229 5.035e-12 2.662e-10
89 EPITHELIAL CELL DIFFERENTIATION 11 495 6.232e-12 3.258e-10
90 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 9 236 6.601e-12 3.412e-10
91 DIGESTIVE SYSTEM DEVELOPMENT 8 148 7.225e-12 3.694e-10
92 HAIR CYCLE 7 83 7.409e-12 3.707e-10
93 MOLTING CYCLE 7 83 7.409e-12 3.707e-10
94 NEUROGENESIS 15 1402 7.55e-12 3.737e-10
95 POSITIVE REGULATION OF OSSIFICATION 7 84 8.076e-12 3.956e-10
96 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 5 16 8.628e-12 4.182e-10
97 RESPONSE TO ENDOGENOUS STIMULUS 15 1450 1.224e-11 5.873e-10
98 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 12 740 2.014e-11 9.562e-10
99 POSITIVE REGULATION OF LOCOMOTION 10 420 3.7e-11 1.739e-09
100 RESPONSE TO ABIOTIC STIMULUS 13 1024 4.514e-11 2.101e-09
101 POSITIVE REGULATION OF RESPONSE TO STIMULUS 16 1929 4.635e-11 2.135e-09
102 MUSCLE STRUCTURE DEVELOPMENT 10 432 4.877e-11 2.225e-09
103 UROGENITAL SYSTEM DEVELOPMENT 9 299 5.48e-11 2.475e-09
104 FORMATION OF PRIMARY GERM LAYER 7 110 5.559e-11 2.487e-09
105 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 7 111 5.928e-11 2.627e-09
106 REGULATION OF OSTEOBLAST DIFFERENTIATION 7 112 6.318e-11 2.773e-09
107 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 7 115 7.623e-11 3.284e-09
108 REGULATION OF WNT SIGNALING PATHWAY 9 310 7.558e-11 3.284e-09
109 RESPONSE TO OXYGEN LEVELS 9 311 7.777e-11 3.32e-09
110 MAMMARY GLAND DEVELOPMENT 7 117 8.615e-11 3.644e-09
111 NEGATIVE REGULATION OF CELL PROLIFERATION 11 643 1.031e-10 4.322e-09
112 KIDNEY EPITHELIUM DEVELOPMENT 7 125 1.376e-10 5.7e-09
113 NEURON DIFFERENTIATION 12 874 1.384e-10 5.7e-09
114 AXIS ELONGATION 5 27 1.58e-10 6.449e-09
115 MESODERM MORPHOGENESIS 6 66 1.725e-10 6.98e-09
116 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 6 67 1.893e-10 7.594e-09
117 CELL FATE COMMITMENT 8 227 2.23e-10 8.868e-09
118 EPIDERMIS MORPHOGENESIS 5 29 2.32e-10 9.15e-09
119 FOREBRAIN DEVELOPMENT 9 357 2.642e-10 1.033e-08
120 PLACENTA DEVELOPMENT 7 138 2.768e-10 1.073e-08
121 HEAD DEVELOPMENT 11 709 2.915e-10 1.121e-08
122 BLOOD VESSEL MORPHOGENESIS 9 364 3.137e-10 1.197e-08
123 REGULATION OF CELL CYCLE 12 949 3.569e-10 1.35e-08
124 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 7 144 3.736e-10 1.402e-08
125 POSITIVE REGULATION OF CELL COMMUNICATION 14 1532 4.505e-10 1.677e-08
126 EPIDERMIS DEVELOPMENT 8 253 5.273e-10 1.947e-08
127 REGULATION OF CELL MORPHOGENESIS 10 552 5.327e-10 1.952e-08
128 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 10 554 5.517e-10 2.005e-08
129 REGULATION OF CELL CYCLE PROCESS 10 558 5.915e-10 2.134e-08
130 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 7 154 5.988e-10 2.143e-08
131 GASTRULATION 7 155 6.266e-10 2.209e-08
132 EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 4 11 6.227e-10 2.209e-08
133 REGULATION OF CELLULAR COMPONENT BIOGENESIS 11 767 6.702e-10 2.345e-08
134 EMBRYONIC PLACENTA DEVELOPMENT 6 83 7.068e-10 2.454e-08
135 PALATE DEVELOPMENT 6 85 8.176e-10 2.818e-08
136 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 7 162 8.54e-10 2.922e-08
137 IMMUNE SYSTEM DEVELOPMENT 10 582 8.893e-10 3.019e-08
138 GROWTH 9 410 8.953e-10 3.019e-08
139 PATTERN SPECIFICATION PROCESS 9 418 1.061e-09 3.552e-08
140 EMBRYONIC ORGAN MORPHOGENESIS 8 279 1.142e-09 3.763e-08
141 APPENDAGE DEVELOPMENT 7 169 1.148e-09 3.763e-08
142 LIMB DEVELOPMENT 7 169 1.148e-09 3.763e-08
143 MESONEPHROS DEVELOPMENT 6 90 1.159e-09 3.772e-08
144 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 14 1656 1.256e-09 4.059e-08
145 REGULATION OF BINDING 8 283 1.278e-09 4.102e-08
146 PROSTATE GLAND DEVELOPMENT 5 41 1.45e-09 4.62e-08
147 CANONICAL WNT SIGNALING PATHWAY 6 95 1.612e-09 5.101e-08
148 ANGIOGENESIS 8 293 1.681e-09 5.283e-08
149 REGULATION OF GROWTH 10 633 2e-09 6.247e-08
150 NEGATIVE REGULATION OF CELL DEVELOPMENT 8 303 2.188e-09 6.783e-08
151 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 6 100 2.201e-09 6.783e-08
152 CAMERA TYPE EYE MORPHOGENESIS 6 101 2.338e-09 7.158e-08
153 EXOCRINE SYSTEM DEVELOPMENT 5 45 2.355e-09 7.163e-08
154 ENDOCARDIAL CUSHION FORMATION 4 15 2.567e-09 7.706e-08
155 REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS 4 15 2.567e-09 7.706e-08
156 CENTRAL NERVOUS SYSTEM DEVELOPMENT 11 872 2.586e-09 7.713e-08
157 REGULATION OF MUSCLE TISSUE DEVELOPMENT 6 103 2.634e-09 7.757e-08
158 REGULATION OF MUSCLE ORGAN DEVELOPMENT 6 103 2.634e-09 7.757e-08
159 IN UTERO EMBRYONIC DEVELOPMENT 8 311 2.686e-09 7.859e-08
160 CARDIAC CHAMBER MORPHOGENESIS 6 104 2.793e-09 8.072e-08
161 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 6 104 2.793e-09 8.072e-08
162 VASCULATURE DEVELOPMENT 9 469 2.908e-09 8.352e-08
163 CARDIAC VENTRICLE DEVELOPMENT 6 106 3.135e-09 8.894e-08
164 RESPONSE TO LIPID 11 888 3.128e-09 8.894e-08
165 DIGESTIVE TRACT MORPHOGENESIS 5 48 3.293e-09 9.286e-08
166 RESPIRATORY SYSTEM DEVELOPMENT 7 197 3.345e-09 9.319e-08
167 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 7 197 3.345e-09 9.319e-08
168 EYE DEVELOPMENT 8 326 3.886e-09 1.076e-07
169 REGULATION OF ORGANELLE ORGANIZATION 12 1178 4.193e-09 1.154e-07
170 RESPONSE TO EXTERNAL STIMULUS 14 1821 4.354e-09 1.192e-07
171 BRANCH ELONGATION OF AN EPITHELIUM 4 17 4.468e-09 1.213e-07
172 POSITIVE REGULATION OF CELL CYCLE 8 332 4.483e-09 1.213e-07
173 DEVELOPMENTAL GROWTH 8 333 4.59e-09 1.235e-07
174 REGULATION OF CELLULAR RESPONSE TO STRESS 10 691 4.643e-09 1.242e-07
175 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 7 207 4.718e-09 1.254e-07
176 RESPONSE TO STEROID HORMONE 9 497 4.822e-09 1.273e-07
177 NOTCH SIGNALING PATHWAY 6 114 4.869e-09 1.273e-07
178 REGULATION OF EMBRYONIC DEVELOPMENT 6 114 4.869e-09 1.273e-07
179 MAMMARY GLAND EPITHELIUM DEVELOPMENT 5 53 5.496e-09 1.429e-07
180 MESODERM DEVELOPMENT 6 118 5.996e-09 1.55e-07
181 CARDIAC MUSCLE TISSUE MORPHOGENESIS 5 54 6.052e-09 1.556e-07
182 REGULATION OF KIDNEY DEVELOPMENT 5 55 6.651e-09 1.7e-07
183 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 5 56 7.297e-09 1.855e-07
184 REGULATION OF APOPTOTIC SIGNALING PATHWAY 8 363 9.008e-09 2.278e-07
185 HEPATICOBILIARY SYSTEM DEVELOPMENT 6 128 9.789e-09 2.462e-07
186 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 10 750 1.016e-08 2.542e-07
187 TUBE FORMATION 6 129 1.026e-08 2.552e-07
188 STEM CELL PROLIFERATION 5 60 1.04e-08 2.574e-07
189 REGULATION OF VASCULATURE DEVELOPMENT 7 233 1.07e-08 2.635e-07
190 POSITIVE REGULATION OF CELL ADHESION 8 376 1.185e-08 2.902e-07
191 MUSCLE CELL DIFFERENTIATION 7 237 1.204e-08 2.932e-07
192 CARDIAC VENTRICLE MORPHOGENESIS 5 62 1.23e-08 2.981e-07
193 SENSORY ORGAN MORPHOGENESIS 7 239 1.276e-08 3.075e-07
194 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 6 134 1.289e-08 3.092e-07
195 SOMATIC STEM CELL DIVISION 4 22 1.368e-08 3.263e-07
196 EYE MORPHOGENESIS 6 136 1.409e-08 3.345e-07
197 CARDIAC MUSCLE TISSUE DEVELOPMENT 6 140 1.677e-08 3.96e-07
198 OSSIFICATION 7 251 1.788e-08 4.202e-07
199 ORGAN GROWTH 5 68 1.972e-08 4.61e-07
200 CARDIAC CHAMBER DEVELOPMENT 6 144 1.985e-08 4.618e-07
201 NEGATIVE REGULATION OF OSSIFICATION 5 69 2.124e-08 4.916e-07
202 RESPONSE TO ESTRADIOL 6 146 2.156e-08 4.966e-07
203 MUSCLE ORGAN MORPHOGENESIS 5 70 2.285e-08 5.238e-07
204 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 25 2.359e-08 5.354e-07
205 POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 4 25 2.359e-08 5.354e-07
206 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 7 262 2.402e-08 5.425e-07
207 POSITIVE REGULATION OF CELL DEATH 9 605 2.648e-08 5.953e-07
208 REGULATION OF MUSCLE CELL DIFFERENTIATION 6 152 2.743e-08 6.137e-07
209 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 4 26 2.786e-08 6.172e-07
210 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 4 26 2.786e-08 6.172e-07
211 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 5 73 2.829e-08 6.238e-07
212 REGULATION OF CELL DIVISION 7 272 3.106e-08 6.817e-07
213 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 5 75 3.245e-08 7.089e-07
214 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 27 3.267e-08 7.104e-07
215 MUSCLE TISSUE DEVELOPMENT 7 275 3.349e-08 7.248e-07
216 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 8 437 3.805e-08 8.129e-07
217 REGULATION OF NEUROBLAST PROLIFERATION 4 28 3.809e-08 8.129e-07
218 MAMMARY GLAND DUCT MORPHOGENESIS 4 28 3.809e-08 8.129e-07
219 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 4 29 4.414e-08 9.294e-07
220 STEM CELL DIVISION 4 29 4.414e-08 9.294e-07
221 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 29 4.414e-08 9.294e-07
222 REGULATION OF EPITHELIAL CELL MIGRATION 6 166 4.641e-08 9.727e-07
223 REGULATION OF RESPONSE TO STRESS 12 1468 4.946e-08 1.032e-06
224 SMOOTH MUSCLE CELL DIFFERENTIATION 4 30 5.089e-08 1.057e-06
225 RESPONSE TO HORMONE 10 893 5.311e-08 1.098e-06
226 ORGAN REGENERATION 5 83 5.423e-08 1.116e-06
227 REGULATION OF MAPK CASCADE 9 660 5.592e-08 1.146e-06
228 GLIOGENESIS 6 175 6.354e-08 1.297e-06
229 SALIVARY GLAND DEVELOPMENT 4 32 6.667e-08 1.349e-06
230 REGULATION OF ORGAN FORMATION 4 32 6.667e-08 1.349e-06
231 TISSUE REMODELING 5 87 6.878e-08 1.385e-06
232 REGIONALIZATION 7 311 7.769e-08 1.558e-06
233 REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 34 8.583e-08 1.714e-06
234 EPITHELIAL CELL DEVELOPMENT 6 186 9.125e-08 1.814e-06
235 EAR DEVELOPMENT 6 195 1.207e-07 2.39e-06
236 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 4 37 1.219e-07 2.394e-06
237 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 4 37 1.219e-07 2.394e-06
238 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 6 200 1.402e-07 2.742e-06
239 SKELETAL SYSTEM MORPHOGENESIS 6 201 1.444e-07 2.812e-06
240 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 4 39 1.516e-07 2.939e-06
241 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 5 103 1.608e-07 3.105e-06
242 MAMMARY GLAND MORPHOGENESIS 4 40 1.683e-07 3.236e-06
243 ODONTOGENESIS 5 105 1.771e-07 3.391e-06
244 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 10 1036 2.134e-07 4.054e-06
245 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 10 1036 2.134e-07 4.054e-06
246 REGULATION OF CELLULAR PROTEIN LOCALIZATION 8 552 2.288e-07 4.327e-06
247 RESPONSE TO ESTROGEN 6 218 2.332e-07 4.375e-06
248 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 6 218 2.332e-07 4.375e-06
249 REGULATION OF CYTOKINE PRODUCTION 8 563 2.659e-07 4.969e-06
250 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 4 45 2.732e-07 5.085e-06
251 NEPHRON DEVELOPMENT 5 115 2.791e-07 5.174e-06
252 REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY 3 11 2.828e-07 5.201e-06
253 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 3 11 2.828e-07 5.201e-06
254 REGULATION OF CHONDROCYTE DIFFERENTIATION 4 46 2.99e-07 5.477e-06
255 REGULATION OF CELL CELL ADHESION 7 380 3.027e-07 5.524e-06
256 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 8 573 3.04e-07 5.526e-06
257 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 48 3.559e-07 6.444e-06
258 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 5 121 3.597e-07 6.487e-06
259 REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS 3 12 3.767e-07 6.742e-06
260 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 3 12 3.767e-07 6.742e-06
261 POSITIVE REGULATION OF GROWTH 6 238 3.907e-07 6.966e-06
262 FACE DEVELOPMENT 4 50 4.205e-07 7.469e-06
263 POSITIVE REGULATION OF BINDING 5 127 4.577e-07 8.098e-06
264 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 7 406 4.729e-07 8.335e-06
265 PROTEIN LOCALIZATION 12 1805 4.792e-07 8.414e-06
266 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 3 13 4.894e-07 8.465e-06
267 POSITIVE REGULATION OF CELL CYCLE PROCESS 6 247 4.858e-07 8.465e-06
268 CARDIOBLAST DIFFERENTIATION 3 13 4.894e-07 8.465e-06
269 MESENCHYMAL CELL PROLIFERATION 3 13 4.894e-07 8.465e-06
270 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 4 52 4.935e-07 8.505e-06
271 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 10 1135 4.974e-07 8.539e-06
272 POSITIVE REGULATION OF CELL DIVISION 5 132 5.546e-07 9.487e-06
273 NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 4 54 5.756e-07 9.81e-06
274 GLIAL CELL DIFFERENTIATION 5 136 6.431e-07 1.092e-05
275 OUTFLOW TRACT MORPHOGENESIS 4 56 6.673e-07 1.129e-05
276 EMBRYONIC PATTERN SPECIFICATION 4 58 7.696e-07 1.297e-05
277 STRIATED MUSCLE CELL PROLIFERATION 3 15 7.773e-07 1.306e-05
278 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 4 60 8.83e-07 1.478e-05
279 RESPONSE TO ORGANIC CYCLIC COMPOUND 9 917 9.054e-07 1.51e-05
280 MORPHOGENESIS OF AN ENDOTHELIUM 3 16 9.558e-07 1.588e-05
281 CELLULAR RESPONSE TO LIPID 7 457 1.046e-06 1.731e-05
282 NEUROEPITHELIAL CELL DIFFERENTIATION 4 63 1.076e-06 1.775e-05
283 CELL DIVISION 7 460 1.092e-06 1.796e-05
284 NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 3 17 1.16e-06 1.88e-05
285 NEGATIVE REGULATION OF STEM CELL PROLIFERATION 3 17 1.16e-06 1.88e-05
286 POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 3 17 1.16e-06 1.88e-05
287 PROTEIN PHOSPHORYLATION 9 944 1.154e-06 1.88e-05
288 REGULATION OF PROTEIN LOCALIZATION 9 950 1.216e-06 1.965e-05
289 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 8 689 1.225e-06 1.972e-05
290 PROTEIN LOCALIZATION TO NUCLEUS 5 156 1.268e-06 2.035e-05
291 IMMUNE SYSTEM PROCESS 12 1984 1.33e-06 2.127e-05
292 REGULATION OF PHOSPHORUS METABOLIC PROCESS 11 1618 1.443e-06 2.299e-05
293 REGULATION OF CELL JUNCTION ASSEMBLY 4 68 1.465e-06 2.321e-05
294 REGULATION OF CELLULAR LOCALIZATION 10 1277 1.467e-06 2.321e-05
295 REGENERATION 5 161 1.482e-06 2.337e-05
296 REGULATION OF NUCLEAR DIVISION 5 163 1.575e-06 2.475e-05
297 MUSCLE CELL PROLIFERATION 3 19 1.65e-06 2.576e-05
298 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 3 19 1.65e-06 2.576e-05
299 ENDODERM DEVELOPMENT 4 71 1.743e-06 2.704e-05
300 CELL FATE SPECIFICATION 4 71 1.743e-06 2.704e-05
301 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 8 724 1.776e-06 2.745e-05
302 TRACHEA DEVELOPMENT 3 20 1.939e-06 2.968e-05
303 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 3 20 1.939e-06 2.968e-05
304 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 3 20 1.939e-06 2.968e-05
305 EMBRYONIC HEART TUBE DEVELOPMENT 4 73 1.949e-06 2.974e-05
306 NEURAL CREST CELL DIFFERENTIATION 4 75 2.173e-06 3.305e-05
307 POSITIVE REGULATION OF NEUROBLAST PROLIFERATION 3 21 2.261e-06 3.426e-05
308 DIENCEPHALON DEVELOPMENT 4 77 2.416e-06 3.649e-05
309 REGULATION OF PROTEIN MODIFICATION PROCESS 11 1710 2.492e-06 3.753e-05
310 RENAL TUBULE DEVELOPMENT 4 78 2.544e-06 3.819e-05
311 EMBRYONIC PLACENTA MORPHOGENESIS 3 22 2.616e-06 3.913e-05
312 RESPONSE TO METAL ION 6 333 2.761e-06 4.105e-05
313 MULTICELLULAR ORGANISM REPRODUCTION 8 768 2.757e-06 4.105e-05
314 REGULATION OF PROTEIN IMPORT 5 183 2.781e-06 4.121e-05
315 CELLULAR RESPONSE TO MECHANICAL STIMULUS 4 80 2.816e-06 4.16e-05
316 POSITIVE REGULATION OF DNA METABOLIC PROCESS 5 185 2.933e-06 4.305e-05
317 CELL JUNCTION ORGANIZATION 5 185 2.933e-06 4.305e-05
318 METANEPHROS DEVELOPMENT 4 81 2.96e-06 4.331e-05
319 RESPONSE TO OXYGEN CONTAINING COMPOUND 10 1381 2.986e-06 4.355e-05
320 PROSTATE GLAND MORPHOGENESIS 3 23 3.005e-06 4.356e-05
321 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS 3 23 3.005e-06 4.356e-05
322 REGULATION OF DNA METABOLIC PROCESS 6 340 3.114e-06 4.499e-05
323 MYELOID CELL DIFFERENTIATION 5 189 3.257e-06 4.692e-05
324 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 5 190 3.342e-06 4.8e-05
325 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 5 191 3.429e-06 4.869e-05
326 NEGATIVE REGULATION OF STEROID METABOLIC PROCESS 3 24 3.432e-06 4.869e-05
327 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 3 24 3.432e-06 4.869e-05
328 NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 3 24 3.432e-06 4.869e-05
329 POSITIVE REGULATION OF CHROMATIN MODIFICATION 4 85 3.59e-06 5.078e-05
330 ANTERIOR POSTERIOR PATTERN SPECIFICATION 5 194 3.701e-06 5.218e-05
331 WNT SIGNALING PATHWAY 6 351 3.74e-06 5.258e-05
332 REGULATION OF NEURON DIFFERENTIATION 7 554 3.752e-06 5.259e-05
333 PROTEIN LOCALIZATION TO ORGANELLE 7 556 3.843e-06 5.369e-05
334 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 3 25 3.897e-06 5.412e-05
335 LUNG CELL DIFFERENTIATION 3 25 3.897e-06 5.412e-05
336 POSITIVE REGULATION OF MOLECULAR FUNCTION 11 1791 3.927e-06 5.438e-05
337 EPITHELIAL CELL PROLIFERATION 4 89 4.315e-06 5.957e-05
338 HEART TRABECULA MORPHOGENESIS 3 26 4.401e-06 6.041e-05
339 HEART GROWTH 3 26 4.401e-06 6.041e-05
340 RESPONSE TO ALCOHOL 6 362 4.466e-06 6.112e-05
341 POSITIVE REGULATION OF HEART GROWTH 3 27 4.947e-06 6.673e-05
342 DEVELOPMENTAL INDUCTION 3 27 4.947e-06 6.673e-05
343 RESPONSE TO LITHIUM ION 3 27 4.947e-06 6.673e-05
344 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 6 368 4.908e-06 6.673e-05
345 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 3 27 4.947e-06 6.673e-05
346 NEPHRON EPITHELIUM DEVELOPMENT 4 93 5.142e-06 6.895e-05
347 REGULATION OF DNA BINDING 4 93 5.142e-06 6.895e-05
348 LYMPHOCYTE DIFFERENTIATION 5 209 5.323e-06 7.118e-05
349 VENTRICULAR SEPTUM MORPHOGENESIS 3 28 5.537e-06 7.339e-05
350 DOPAMINERGIC NEURON DIFFERENTIATION 3 28 5.537e-06 7.339e-05
351 METANEPHROS MORPHOGENESIS 3 28 5.537e-06 7.339e-05
352 MYELOID LEUKOCYTE DIFFERENTIATION 4 96 5.836e-06 7.714e-05
353 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 10 1492 5.984e-06 7.888e-05
354 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 3 29 6.17e-06 8.087e-05
355 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 3 29 6.17e-06 8.087e-05
356 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 5 220 6.833e-06 8.931e-05
357 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 4 100 6.866e-06 8.948e-05
358 POSITIVE REGULATION OF CATALYTIC ACTIVITY 10 1518 6.983e-06 9.076e-05
359 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 8 876 7.296e-06 9.456e-05
360 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 4 102 7.428e-06 9.601e-05
361 NEURON PROJECTION MORPHOGENESIS 6 402 8.139e-06 0.0001046
362 TELENCEPHALON DEVELOPMENT 5 228 8.128e-06 0.0001046
363 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA 3 32 8.355e-06 0.0001071
364 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 5 232 8.843e-06 0.000113
365 REGULATION OF T CELL APOPTOTIC PROCESS 3 33 9.183e-06 0.0001161
366 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 3 33 9.183e-06 0.0001161
367 EMBRYONIC EYE MORPHOGENESIS 3 33 9.183e-06 0.0001161
368 CELLULAR RESPONSE TO STRESS 10 1565 9.163e-06 0.0001161
369 ORGAN FORMATION 3 34 1.006e-05 0.0001262
370 HEART VALVE DEVELOPMENT 3 34 1.006e-05 0.0001262
371 PHOSPHORYLATION 9 1228 1.003e-05 0.0001262
372 CELLULAR MACROMOLECULE LOCALIZATION 9 1234 1.043e-05 0.0001305
373 HAIR CELL DIFFERENTIATION 3 35 1.1e-05 0.0001368
374 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 3 35 1.1e-05 0.0001368
375 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 3 36 1.199e-05 0.0001483
376 HEAD MORPHOGENESIS 3 36 1.199e-05 0.0001483
377 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 4 117 1.28e-05 0.0001575
378 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 4 117 1.28e-05 0.0001575
379 MYOBLAST DIFFERENTIATION 3 37 1.303e-05 0.00016
380 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 6 437 1.309e-05 0.0001603
381 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 4 118 1.323e-05 0.0001616
382 LEUKOCYTE CELL CELL ADHESION 5 255 1.397e-05 0.0001702
383 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 3 38 1.414e-05 0.0001713
384 POSITIVE REGULATION OF ORGAN GROWTH 3 38 1.414e-05 0.0001713
385 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 7 684 1.489e-05 0.00018
386 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 4 122 1.51e-05 0.0001815
387 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 4 122 1.51e-05 0.0001815
388 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 3 39 1.531e-05 0.0001831
389 TRABECULA MORPHOGENESIS 3 39 1.531e-05 0.0001831
390 ENDOCRINE SYSTEM DEVELOPMENT 4 123 1.559e-05 0.0001855
391 T CELL DIFFERENTIATION 4 123 1.559e-05 0.0001855
392 NEGATIVE REGULATION OF LOCOMOTION 5 263 1.622e-05 0.000192
393 CELLULAR RESPONSE TO ABIOTIC STIMULUS 5 263 1.622e-05 0.000192
394 CELLULAR RESPONSE TO EXTERNAL STIMULUS 5 264 1.651e-05 0.0001943
395 AGING 5 264 1.651e-05 0.0001943
396 POSITIVE REGULATION OF CELL MATRIX ADHESION 3 40 1.653e-05 0.0001943
397 SEX DIFFERENTIATION 5 266 1.713e-05 0.0002007
398 SINGLE ORGANISM CELL ADHESION 6 459 1.729e-05 0.0002021
399 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 3 41 1.782e-05 0.0002079
400 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 6 465 1.86e-05 0.0002164
401 PITUITARY GLAND DEVELOPMENT 3 42 1.918e-05 0.0002209
402 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 3 42 1.918e-05 0.0002209
403 REGULATION OF HEART GROWTH 3 42 1.918e-05 0.0002209
404 GENITALIA DEVELOPMENT 3 42 1.918e-05 0.0002209
405 POSITIVE REGULATION OF MAPK CASCADE 6 470 1.976e-05 0.0002265
406 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 5 274 1.975e-05 0.0002265
407 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 3 43 2.06e-05 0.0002349
408 MAINTENANCE OF CELL NUMBER 4 132 2.059e-05 0.0002349
409 MUSCLE ORGAN DEVELOPMENT 5 277 2.081e-05 0.0002368
410 LABYRINTHINE LAYER DEVELOPMENT 3 44 2.209e-05 0.0002483
411 BODY MORPHOGENESIS 3 44 2.209e-05 0.0002483
412 NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 3 44 2.209e-05 0.0002483
413 RESPONSE TO INORGANIC SUBSTANCE 6 479 2.199e-05 0.0002483
414 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 3 44 2.209e-05 0.0002483
415 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 4 135 2.25e-05 0.0002516
416 CELL GROWTH 4 135 2.25e-05 0.0002516
417 LUNG MORPHOGENESIS 3 45 2.365e-05 0.0002626
418 SPROUTING ANGIOGENESIS 3 45 2.365e-05 0.0002626
419 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 3 45 2.365e-05 0.0002626
420 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 4 138 2.453e-05 0.0002717
421 REGULATION OF DEVELOPMENTAL GROWTH 5 289 2.551e-05 0.0002819
422 NON CANONICAL WNT SIGNALING PATHWAY 4 140 2.595e-05 0.0002862
423 LEUKOCYTE DIFFERENTIATION 5 292 2.68e-05 0.0002948
424 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 3 47 2.698e-05 0.0002961
425 EPIDERMAL CELL DIFFERENTIATION 4 142 2.744e-05 0.0003004
426 CELLULAR RESPONSE TO OXYGEN LEVELS 4 143 2.82e-05 0.0003073
427 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 4 143 2.82e-05 0.0003073
428 REGULATION OF MYOBLAST DIFFERENTIATION 3 48 2.875e-05 0.0003119
429 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 3 48 2.875e-05 0.0003119
430 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 4 145 2.978e-05 0.0003223
431 REGULATION OF STEROID BIOSYNTHETIC PROCESS 3 49 3.06e-05 0.0003296
432 CARDIAC SEPTUM MORPHOGENESIS 3 49 3.06e-05 0.0003296
433 CELL CELL SIGNALING 7 767 3.115e-05 0.0003348
434 REGULATION OF TRANSPORT 10 1804 3.2e-05 0.0003423
435 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 5 303 3.199e-05 0.0003423
436 MALE SEX DIFFERENTIATION 4 148 3.227e-05 0.0003444
437 EXTRACELLULAR STRUCTURE ORGANIZATION 5 304 3.25e-05 0.000346
438 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 6 514 3.269e-05 0.0003473
439 POSITIVE REGULATION OF NEURON DIFFERENTIATION 5 306 3.353e-05 0.0003554
440 CELL CYCLE PROCESS 8 1081 3.362e-05 0.0003556
441 POSITIVE REGULATION OF CHROMOSOME ORGANIZATION 4 150 3.401e-05 0.0003585
442 REGULATION OF PROTEIN TARGETING 5 307 3.406e-05 0.0003585
443 REGULATION OF CHROMATIN ORGANIZATION 4 152 3.582e-05 0.0003754
444 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 4 152 3.582e-05 0.0003754
445 NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 3 52 3.662e-05 0.0003829
446 PALLIUM DEVELOPMENT 4 153 3.675e-05 0.0003834
447 AMEBOIDAL TYPE CELL MIGRATION 4 154 3.77e-05 0.0003924
448 REGULATION OF HEMOPOIESIS 5 314 3.793e-05 0.0003939
449 MESONEPHRIC TUBULE MORPHOGENESIS 3 53 3.878e-05 0.0004019
450 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 4 156 3.965e-05 0.0004091
451 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 4 156 3.965e-05 0.0004091
452 RESPONSE TO ACID CHEMICAL 5 319 4.089e-05 0.0004196
453 REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 3 54 4.103e-05 0.0004196
454 VENTRICULAR SEPTUM DEVELOPMENT 3 54 4.103e-05 0.0004196
455 REGULATION OF MAP KINASE ACTIVITY 5 319 4.089e-05 0.0004196
456 CHROMATIN MODIFICATION 6 539 4.264e-05 0.0004351
457 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 3 55 4.336e-05 0.0004405
458 CRANIAL SKELETAL SYSTEM DEVELOPMENT 3 55 4.336e-05 0.0004405
459 NEURON PROJECTION DEVELOPMENT 6 545 4.536e-05 0.0004598
460 SMAD PROTEIN SIGNAL TRANSDUCTION 3 56 4.578e-05 0.0004631
461 CELLULAR RESPONSE TO BIOTIC STIMULUS 4 163 4.706e-05 0.000475
462 POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 3 57 4.828e-05 0.0004852
463 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 3 57 4.828e-05 0.0004852
464 CELLULAR RESPONSE TO HORMONE STIMULUS 6 552 4.87e-05 0.0004884
465 REGULATION OF PROTEIN BINDING 4 168 5.294e-05 0.0005298
466 POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 3 59 5.355e-05 0.0005336
467 VASCULOGENESIS 3 59 5.355e-05 0.0005336
468 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 3 60 5.633e-05 0.0005564
469 CHONDROCYTE DIFFERENTIATION 3 60 5.633e-05 0.0005564
470 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 3 60 5.633e-05 0.0005564
471 OLIGODENDROCYTE DIFFERENTIATION 3 60 5.633e-05 0.0005564
472 LYMPHOCYTE ACTIVATION 5 342 5.693e-05 0.0005612
473 PROTEIN COMPLEX SUBUNIT ORGANIZATION 9 1527 5.715e-05 0.0005622
474 EMBRYONIC DIGIT MORPHOGENESIS 3 61 5.919e-05 0.0005798
475 REGULATION OF VIRAL TRANSCRIPTION 3 61 5.919e-05 0.0005798
476 REGULATION OF CELL SUBSTRATE ADHESION 4 173 5.935e-05 0.0005801
477 SOMITOGENESIS 3 62 6.215e-05 0.0006012
478 HOMEOSTASIS OF NUMBER OF CELLS 4 175 6.206e-05 0.0006012
479 POSITIVE REGULATION OF NUCLEAR DIVISION 3 62 6.215e-05 0.0006012
480 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 3 62 6.215e-05 0.0006012
481 EMBRYONIC HEART TUBE MORPHOGENESIS 3 62 6.215e-05 0.0006012
482 RESPONSE TO CORTICOSTEROID 4 176 6.345e-05 0.0006125
483 SECRETION 6 588 6.918e-05 0.0006665
484 REGULATION OF CHEMOKINE PRODUCTION 3 65 7.16e-05 0.0006869
485 REGULATION OF RESPONSE TO OXIDATIVE STRESS 3 65 7.16e-05 0.0006869
486 RESPONSE TO KETONE 4 182 7.227e-05 0.0006919
487 FOREBRAIN GENERATION OF NEURONS 3 66 7.495e-05 0.0007146
488 LENS DEVELOPMENT IN CAMERA TYPE EYE 3 66 7.495e-05 0.0007146
489 POSITIVE REGULATION OF NEURON DEATH 3 67 7.84e-05 0.0007414
490 REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS 3 67 7.84e-05 0.0007414
491 NEURON FATE COMMITMENT 3 67 7.84e-05 0.0007414
492 RESPONSE TO BIOTIC STIMULUS 7 886 7.795e-05 0.0007414
493 POSITIVE REGULATION OF HORMONE METABOLIC PROCESS 2 11 8.194e-05 0.000761
494 ENDOCARDIUM DEVELOPMENT 2 11 8.194e-05 0.000761
495 NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 2 11 8.194e-05 0.000761
496 RESPONSE TO FOLLICLE STIMULATING HORMONE 2 11 8.194e-05 0.000761
497 MULTI ORGANISM REPRODUCTIVE PROCESS 7 891 8.076e-05 0.000761
498 PROSTATE GLAND GROWTH 2 11 8.194e-05 0.000761
499 VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS 2 11 8.194e-05 0.000761
500 PROSTATE GLANDULAR ACINUS DEVELOPMENT 2 11 8.194e-05 0.000761
501 ENDOTHELIAL TUBE MORPHOGENESIS 2 11 8.194e-05 0.000761
502 POSITIVE REGULATION OF CYTOKINE PRODUCTION 5 370 8.26e-05 0.0007657
503 CELL CELL ADHESION 6 608 8.324e-05 0.00077
504 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 5 372 8.473e-05 0.0007823
505 RESPONSE TO ACTIVITY 3 69 8.56e-05 0.0007887
506 REGULATION OF NEURON APOPTOTIC PROCESS 4 192 8.892e-05 0.0008177
507 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 6 616 8.946e-05 0.0008211
508 DEVELOPMENTAL MATURATION 4 193 9.072e-05 0.000831
509 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 3 71 9.323e-05 0.0008522
510 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 5 381 9.483e-05 0.0008652
511 CARDIAC LEFT VENTRICLE MORPHOGENESIS 2 12 9.825e-05 0.0008842
512 REGULATION OF TIMING OF CELL DIFFERENTIATION 2 12 9.825e-05 0.0008842
513 CARTILAGE MORPHOGENESIS 2 12 9.825e-05 0.0008842
514 ENDOTHELIAL CELL DIFFERENTIATION 3 72 9.72e-05 0.0008842
515 REGULATION OF VITAMIN METABOLIC PROCESS 2 12 9.825e-05 0.0008842
516 REGULATION OF THYMOCYTE APOPTOTIC PROCESS 2 12 9.825e-05 0.0008842
517 REGULATION OF DEVELOPMENT HETEROCHRONIC 2 12 9.825e-05 0.0008842
518 PANCREAS DEVELOPMENT 3 73 0.0001013 0.000908
519 REGULATION OF ORGAN GROWTH 3 73 0.0001013 0.000908
520 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 4 199 0.0001021 0.0009138
521 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 7 926 0.0001029 0.000919
522 CELL PART MORPHOGENESIS 6 633 0.0001039 0.0009264
523 REGULATION OF STEROID METABOLIC PROCESS 3 74 0.0001055 0.0009384
524 REGULATION OF CELL GROWTH 5 391 0.0001071 0.0009512
525 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 3 75 0.0001098 0.000973
526 NEURONAL STEM CELL DIVISION 2 13 0.000116 0.001007
527 NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 2 13 0.000116 0.001007
528 REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 4 205 0.0001145 0.001007
529 CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS 2 13 0.000116 0.001007
530 HEART VALVE FORMATION 2 13 0.000116 0.001007
531 RESPONSE TO HEPATOCYTE GROWTH FACTOR 2 13 0.000116 0.001007
532 NEUROBLAST DIVISION 2 13 0.000116 0.001007
533 GLIAL CELL FATE COMMITMENT 2 13 0.000116 0.001007
534 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 2 13 0.000116 0.001007
535 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 2 13 0.000116 0.001007
536 NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 2 13 0.000116 0.001007
537 REGULATION OF TRANSFERASE ACTIVITY 7 946 0.0001176 0.001019
538 REGULATION OF BMP SIGNALING PATHWAY 3 77 0.0001187 0.001027
539 SOMITE DEVELOPMENT 3 78 0.0001234 0.001065
540 RESPONSE TO PEPTIDE 5 404 0.0001249 0.001074
541 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 5 404 0.0001249 0.001074
542 RESPONSE TO MECHANICAL STIMULUS 4 210 0.0001257 0.001079
543 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 3 79 0.0001281 0.001092
544 POSITIVE REGULATION OF PROTEIN SECRETION 4 211 0.000128 0.001092
545 BONE MORPHOGENESIS 3 79 0.0001281 0.001092
546 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 4 211 0.000128 0.001092
547 REGULATION OF NEURON PROJECTION DEVELOPMENT 5 408 0.0001308 0.001112
548 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 2 14 0.0001353 0.001121
549 NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 3 80 0.000133 0.001121
550 RENAL VESICLE DEVELOPMENT 2 14 0.0001353 0.001121
551 SPECIFICATION OF ORGAN IDENTITY 2 14 0.0001353 0.001121
552 POSITIVE REGULATION OF MEIOTIC CELL CYCLE 2 14 0.0001353 0.001121
553 CHROMATIN ORGANIZATION 6 663 0.000134 0.001121
554 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 3 80 0.000133 0.001121
555 EMBRYONIC SKELETAL JOINT DEVELOPMENT 2 14 0.0001353 0.001121
556 MULTI MULTICELLULAR ORGANISM PROCESS 4 213 0.0001327 0.001121
557 METANEPHRIC MESENCHYME DEVELOPMENT 2 14 0.0001353 0.001121
558 CELL CYCLE 8 1316 0.0001354 0.001121
559 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 2 14 0.0001353 0.001121
560 CONVERGENT EXTENSION 2 14 0.0001353 0.001121
561 REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 2 14 0.0001353 0.001121
562 MIDGUT DEVELOPMENT 2 14 0.0001353 0.001121
563 REGULATION OF FIBROBLAST PROLIFERATION 3 81 0.000138 0.001141
564 LEUKOCYTE ACTIVATION 5 414 0.00014 0.001154
565 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 4 216 0.0001401 0.001154
566 KIDNEY MORPHOGENESIS 3 82 0.0001431 0.001177
567 REGULATION OF HYDROLASE ACTIVITY 8 1327 0.0001435 0.001178
568 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 4 218 0.0001451 0.001189
569 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 3 84 0.0001538 0.001257
570 POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 2 15 0.0001559 0.001264
571 OTIC VESICLE DEVELOPMENT 2 15 0.0001559 0.001264
572 MORPHOGENESIS OF AN EPITHELIAL FOLD 2 15 0.0001559 0.001264
573 POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS 2 15 0.0001559 0.001264
574 EPITHELIAL CELL FATE COMMITMENT 2 15 0.0001559 0.001264
575 NEGATIVE REGULATION OF CELL ADHESION 4 223 0.0001583 0.001281
576 CARDIAC SEPTUM DEVELOPMENT 3 85 0.0001593 0.001284
577 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 3 85 0.0001593 0.001284
578 NEURON DEVELOPMENT 6 687 0.0001627 0.00131
579 CELL DEATH 7 1001 0.0001673 0.001344
580 RESPONSE TO DRUG 5 431 0.000169 0.001356
581 NEGATIVE REGULATION OF CELL CYCLE 5 433 0.0001727 0.001383
582 LEUKOCYTE PROLIFERATION 3 88 0.0001765 0.001409
583 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 3 88 0.0001765 0.001409
584 PARAXIAL MESODERM DEVELOPMENT 2 16 0.0001781 0.001414
585 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 2 16 0.0001781 0.001414
586 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 2 16 0.0001781 0.001414
587 SEGMENTATION 3 89 0.0001825 0.001447
588 AXIS SPECIFICATION 3 90 0.0001886 0.001483
589 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 3 90 0.0001886 0.001483
590 MIDBRAIN DEVELOPMENT 3 90 0.0001886 0.001483
591 ENDOTHELIUM DEVELOPMENT 3 90 0.0001886 0.001483
592 REGULATION OF CELL MATRIX ADHESION 3 90 0.0001886 0.001483
593 NEGATIVE REGULATION OF GROWTH 4 236 0.0001967 0.001544
594 NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 2 17 0.0002017 0.001564
595 CELLULAR RESPONSE TO LITHIUM ION 2 17 0.0002017 0.001564
596 ESTABLISHMENT OF TISSUE POLARITY 2 17 0.0002017 0.001564
597 NEGATIVE REGULATION OF ANOIKIS 2 17 0.0002017 0.001564
598 REGULATION OF STEM CELL POPULATION MAINTENANCE 2 17 0.0002017 0.001564
599 RESPONSE TO CYTOKINE 6 714 0.0002007 0.001564
600 INNER EAR MORPHOGENESIS 3 92 0.0002013 0.001564
601 BIOLOGICAL ADHESION 7 1032 0.0002021 0.001565
602 MACROMOLECULAR COMPLEX ASSEMBLY 8 1398 0.0002061 0.001593
603 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 3 93 0.0002079 0.001604
604 REGULATION OF IMMUNE SYSTEM PROCESS 8 1403 0.0002112 0.001627
605 RESPONSE TO BMP 3 94 0.0002145 0.001645
606 REGULATION OF DNA BIOSYNTHETIC PROCESS 3 94 0.0002145 0.001645
607 CELLULAR RESPONSE TO BMP STIMULUS 3 94 0.0002145 0.001645
608 POSITIVE REGULATION OF CELL CELL ADHESION 4 243 0.00022 0.001684
609 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 3 95 0.0002213 0.001686
610 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 3 95 0.0002213 0.001686
611 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 3 95 0.0002213 0.001686
612 NEGATIVE REGULATION OF TRANSPORT 5 458 0.0002241 0.001704
613 REGULATION OF HORMONE BIOSYNTHETIC PROCESS 2 18 0.0002267 0.00171
614 PERICARDIUM DEVELOPMENT 2 18 0.0002267 0.00171
615 KIDNEY MESENCHYME DEVELOPMENT 2 18 0.0002267 0.00171
616 NEPHRON TUBULE FORMATION 2 18 0.0002267 0.00171
617 NOTOCHORD DEVELOPMENT 2 18 0.0002267 0.00171
618 REGULATION OF CATABOLIC PROCESS 6 731 0.000228 0.001716
619 CARDIOCYTE DIFFERENTIATION 3 96 0.0002283 0.001716
620 ESTABLISHMENT OF PROTEIN LOCALIZATION 8 1423 0.0002329 0.001748
621 TAXIS 5 464 0.0002381 0.001784
622 REGULATION OF MITOTIC CELL CYCLE 5 468 0.0002477 0.001853
623 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 3 99 0.00025 0.001864
624 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 3 99 0.00025 0.001864
625 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 2 19 0.0002532 0.001873
626 WOUND HEALING 5 470 0.0002526 0.001873
627 REGULATION OF NEURON DEATH 4 252 0.0002528 0.001873
628 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 5 470 0.0002526 0.001873
629 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 2 19 0.0002532 0.001873
630 MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM 3 100 0.0002575 0.001899
631 LIMBIC SYSTEM DEVELOPMENT 3 100 0.0002575 0.001899
632 KERATINOCYTE DIFFERENTIATION 3 101 0.0002652 0.001949
633 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 3 101 0.0002652 0.001949
634 NEGATIVE REGULATION OF MOLECULAR FUNCTION 7 1079 0.0002659 0.001951
635 POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 2 20 0.0002811 0.002038
636 NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 2 20 0.0002811 0.002038
637 METANEPHRIC EPITHELIUM DEVELOPMENT 2 20 0.0002811 0.002038
638 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 2 20 0.0002811 0.002038
639 TONGUE DEVELOPMENT 2 20 0.0002811 0.002038
640 REGULATION OF CYTOPLASMIC TRANSPORT 5 481 0.0002812 0.002038
641 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 7 1087 0.0002782 0.002038
642 MYELOID DENDRITIC CELL DIFFERENTIATION 2 20 0.0002811 0.002038
643 SECRETION BY CELL 5 486 0.0002949 0.002134
644 CEREBRAL CORTEX DEVELOPMENT 3 105 0.0002973 0.002148
645 IMMUNE RESPONSE 7 1100 0.0002992 0.002159
646 REGULATION OF FAT CELL DIFFERENTIATION 3 106 0.0003057 0.002199
647 FAT CELL DIFFERENTIATION 3 106 0.0003057 0.002199
648 METANEPHRIC NEPHRON MORPHOGENESIS 2 21 0.0003105 0.002205
649 LEFT RIGHT PATTERN FORMATION 2 21 0.0003105 0.002205
650 CELL AGGREGATION 2 21 0.0003105 0.002205
651 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 2 21 0.0003105 0.002205
652 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 2 21 0.0003105 0.002205
653 COCHLEA MORPHOGENESIS 2 21 0.0003105 0.002205
654 NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 2 21 0.0003105 0.002205
655 CARTILAGE CONDENSATION 2 21 0.0003105 0.002205
656 REGULATION OF KINASE ACTIVITY 6 776 0.0003147 0.002229
657 PLATELET DEGRANULATION 3 107 0.0003143 0.002229
658 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 2 22 0.0003412 0.002399
659 SEX DETERMINATION 2 22 0.0003412 0.002399
660 BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY 2 22 0.0003412 0.002399
661 MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 2 22 0.0003412 0.002399
662 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 2 22 0.0003412 0.002399
663 NEGATIVE REGULATION OF DNA METABOLIC PROCESS 3 111 0.0003501 0.002457
664 PROTEIN COMPLEX BIOGENESIS 7 1132 0.0003565 0.002495
665 PROTEIN COMPLEX ASSEMBLY 7 1132 0.0003565 0.002495
666 EAR MORPHOGENESIS 3 112 0.0003594 0.002511
667 REGULATION OF CHROMOSOME ORGANIZATION 4 278 0.0003671 0.002561
668 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 6 799 0.0003681 0.002564
669 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 2 23 0.0003735 0.00259
670 REGULATION OF SUPEROXIDE METABOLIC PROCESS 2 23 0.0003735 0.00259
671 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 2 23 0.0003735 0.00259
672 REGULATION OF ENDOTHELIAL CELL MIGRATION 3 114 0.0003786 0.002621
673 REGULATION OF LIPID METABOLIC PROCESS 4 282 0.0003875 0.002679
674 RESPONSE TO FIBROBLAST GROWTH FACTOR 3 116 0.0003984 0.00275
675 NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 2 24 0.0004071 0.002798
676 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 2 24 0.0004071 0.002798
677 REGULATION OF ANOIKIS 2 24 0.0004071 0.002798
678 SPECIFICATION OF SYMMETRY 3 117 0.0004085 0.002804
679 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 9 1977 0.0004153 0.002846
680 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 3 119 0.0004293 0.002938
681 RESPONSE TO BACTERIUM 5 528 0.0004316 0.002949
682 CYTOKINE PRODUCTION 3 120 0.00044 0.002997
683 REGULATION OF DENDRITE DEVELOPMENT 3 120 0.00044 0.002997
684 CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS 2 25 0.0004422 0.003003
685 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 2 25 0.0004422 0.003003
686 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 6 829 0.0004482 0.00304
687 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 3 121 0.0004508 0.003053
688 DEVELOPMENTAL PROGRAMMED CELL DEATH 2 26 0.0004786 0.003204
689 NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION 2 26 0.0004786 0.003204
690 REGULATION OF MESONEPHROS DEVELOPMENT 2 26 0.0004786 0.003204
691 MESODERMAL CELL DIFFERENTIATION 2 26 0.0004786 0.003204
692 REGULATION OF HORMONE METABOLIC PROCESS 2 26 0.0004786 0.003204
693 MYELOID DENDRITIC CELL ACTIVATION 2 26 0.0004786 0.003204
694 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 2 26 0.0004786 0.003204
695 REGULATION OF CELL FATE COMMITMENT 2 26 0.0004786 0.003204
696 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 5 541 0.0004823 0.00322
697 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 5 541 0.0004823 0.00322
698 STEROID HORMONE MEDIATED SIGNALING PATHWAY 3 125 0.0004957 0.003305
699 OSTEOBLAST DIFFERENTIATION 3 126 0.0005074 0.003378
700 REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 2 27 0.0005165 0.003419
701 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 2 27 0.0005165 0.003419
702 INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 2 27 0.0005165 0.003419
703 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 2 27 0.0005165 0.003419
704 REGULATION OF LIPID BIOSYNTHETIC PROCESS 3 128 0.0005313 0.003511
705 RESPONSE TO NITROGEN COMPOUND 6 859 0.0005414 0.003573
706 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 3 129 0.0005435 0.003577
707 NUCLEAR IMPORT 3 129 0.0005435 0.003577
708 POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 2 28 0.0005558 0.003622
709 GASTRULATION WITH MOUTH FORMING SECOND 2 28 0.0005558 0.003622
710 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 2 28 0.0005558 0.003622
711 REGULATION OF CELL PROJECTION ORGANIZATION 5 558 0.0005553 0.003622
712 AUDITORY RECEPTOR CELL DIFFERENTIATION 2 28 0.0005558 0.003622
713 MORPHOGENESIS OF A POLARIZED EPITHELIUM 2 28 0.0005558 0.003622
714 RESPONSE TO GONADOTROPIN 2 28 0.0005558 0.003622
715 NEGATIVE REGULATION OF BINDING 3 131 0.0005684 0.003699
716 RESPONSE TO WOUNDING 5 563 0.0005783 0.003758
717 REGULATION OF MEIOTIC NUCLEAR DIVISION 2 29 0.0005966 0.003845
718 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 2 29 0.0005966 0.003845
719 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 3 133 0.0005941 0.003845
720 EMBRYONIC HINDLIMB MORPHOGENESIS 2 29 0.0005966 0.003845
721 REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 2 29 0.0005966 0.003845
722 NEUROBLAST PROLIFERATION 2 29 0.0005966 0.003845
723 CELL ACTIVATION 5 568 0.000602 0.003874
724 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 4 321 0.0006312 0.004056
725 PROTEIN EXPORT FROM NUCLEUS 2 30 0.0006387 0.004082
726 PROTEIN LOCALIZATION TO CYTOSKELETON 2 30 0.0006387 0.004082
727 RESPONSE TO EPIDERMAL GROWTH FACTOR 2 30 0.0006387 0.004082
728 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 2 30 0.0006387 0.004082
729 NEGATIVE REGULATION OF CELL CELL ADHESION 3 138 0.0006614 0.004222
730 HYALURONAN METABOLIC PROCESS 2 31 0.0006822 0.004336
731 CARDIAC ATRIUM DEVELOPMENT 2 31 0.0006822 0.004336
732 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 2 31 0.0006822 0.004336
733 CELL PROJECTION ORGANIZATION 6 902 0.0007008 0.004449
734 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 2 32 0.0007271 0.004584
735 PATTERNING OF BLOOD VESSELS 2 32 0.0007271 0.004584
736 POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 2 32 0.0007271 0.004584
737 METANEPHRIC NEPHRON DEVELOPMENT 2 32 0.0007271 0.004584
738 BLOOD VESSEL REMODELING 2 32 0.0007271 0.004584
739 GAMETE GENERATION 5 595 0.0007428 0.004677
740 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 3 145 0.0007637 0.004802
741 DENDRITIC CELL DIFFERENTIATION 2 33 0.0007734 0.004824
742 EMBRYONIC AXIS SPECIFICATION 2 33 0.0007734 0.004824
743 REGULATION OF MYELINATION 2 33 0.0007734 0.004824
744 RESPONSE TO VITAMIN D 2 33 0.0007734 0.004824
745 POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 2 33 0.0007734 0.004824
746 POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 2 33 0.0007734 0.004824
747 CELLULAR RESPONSE TO CYTOKINE STIMULUS 5 606 0.0008068 0.005026
748 POSITIVE REGULATION OF CELL GROWTH 3 148 0.0008104 0.005041
749 FOREBRAIN NEURON DEVELOPMENT 2 34 0.0008212 0.005081
750 LUNG EPITHELIUM DEVELOPMENT 2 34 0.0008212 0.005081
751 PROTEIN KINASE B SIGNALING 2 34 0.0008212 0.005081
752 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 2 34 0.0008212 0.005081
753 NEURAL TUBE DEVELOPMENT 3 149 0.0008264 0.005107
754 CHROMATIN REMODELING 3 150 0.0008426 0.0052
755 POSITIVE REGULATION OF TRANSPORT 6 936 0.0008511 0.005245
756 NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS 2 35 0.0008703 0.005328
757 BONE REMODELING 2 35 0.0008703 0.005328
758 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 5 616 0.0008685 0.005328
759 NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS 2 35 0.0008703 0.005328
760 REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES 2 35 0.0008703 0.005328
761 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 3 152 0.0008755 0.005353
762 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 3 153 0.0008923 0.005441
763 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 3 153 0.0008923 0.005441
764 REGULATION OF INTRACELLULAR TRANSPORT 5 621 0.0009006 0.005485
765 NUCLEAR TRANSPORT 4 355 0.0009192 0.005564
766 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 2 36 0.0009207 0.005564
767 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 2 36 0.0009207 0.005564
768 POSITIVE REGULATION OF PROTEIN ACETYLATION 2 36 0.0009207 0.005564
769 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 2 36 0.0009207 0.005564
770 POSITIVE CHEMOTAXIS 2 36 0.0009207 0.005564
771 PROTEIN IMPORT 3 155 0.0009264 0.005591
772 BONE DEVELOPMENT 3 156 0.0009438 0.005689
773 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 4 360 0.0009682 0.005828
774 NEGATIVE REGULATION OF GLIOGENESIS 2 37 0.0009726 0.005832
775 HINDLIMB MORPHOGENESIS 2 37 0.0009726 0.005832
776 GLIAL CELL MIGRATION 2 37 0.0009726 0.005832
777 HORMONE MEDIATED SIGNALING PATHWAY 3 158 0.0009792 0.005864
778 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 4 365 0.001019 0.006095
779 COLLAGEN FIBRIL ORGANIZATION 2 38 0.001026 0.006104
780 OOCYTE DIFFERENTIATION 2 38 0.001026 0.006104
781 CYTOKINE SECRETION 2 38 0.001026 0.006104
782 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 2 38 0.001026 0.006104
783 CELL CHEMOTAXIS 3 162 0.001053 0.006255
784 POSITIVE REGULATION OF VIRAL TRANSCRIPTION 2 39 0.00108 0.006348
785 NEGATIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 2 39 0.00108 0.006348
786 POSITIVE REGULATION OF HEMOPOIESIS 3 163 0.001071 0.006348
787 ANATOMICAL STRUCTURE MATURATION 2 39 0.00108 0.006348
788 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 2 39 0.00108 0.006348
789 ASTROCYTE DIFFERENTIATION 2 39 0.00108 0.006348
790 COCHLEA DEVELOPMENT 2 39 0.00108 0.006348
791 NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 2 39 0.00108 0.006348
792 POSITIVE REGULATION OF SECRETION 4 370 0.001072 0.006348
793 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 3 166 0.001129 0.006626
794 REGULATION OF MEIOTIC CELL CYCLE 2 40 0.001136 0.006643
795 ENDOCRINE PANCREAS DEVELOPMENT 2 40 0.001136 0.006643
796 ENDODERMAL CELL DIFFERENTIATION 2 40 0.001136 0.006643
797 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 2 41 0.001194 0.006961
798 LUNG ALVEOLUS DEVELOPMENT 2 41 0.001194 0.006961
799 NEGATIVE REGULATION OF CELL GROWTH 3 170 0.001209 0.007043
800 POSITIVE REGULATION OF DNA BINDING 2 42 0.001253 0.007258
801 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 3 172 0.001251 0.007258
802 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 2 42 0.001253 0.007258
803 REGULATION OF CELL SIZE 3 172 0.001251 0.007258
804 CHROMOSOME ORGANIZATION 6 1009 0.001258 0.007281
805 REGULATION OF PROTEIN SECRETION 4 389 0.00129 0.007448
806 REGULATION OF GTPASE ACTIVITY 5 673 0.00129 0.007448
807 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 2 43 0.001313 0.007541
808 MORPHOGENESIS OF AN EPITHELIAL SHEET 2 43 0.001313 0.007541
809 REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 2 43 0.001313 0.007541
810 BETA CATENIN TCF COMPLEX ASSEMBLY 2 43 0.001313 0.007541
811 CELLULAR RESPONSE TO ACID CHEMICAL 3 175 0.001314 0.007542
812 REGULATION OF PROTEIN CATABOLIC PROCESS 4 393 0.001339 0.007675
813 POSITIVE REGULATION OF CATABOLIC PROCESS 4 395 0.001365 0.00781
814 REGULATION OF CHEMOTAXIS 3 180 0.001425 0.008147
815 THYMOCYTE AGGREGATION 2 45 0.001437 0.008194
816 T CELL DIFFERENTIATION IN THYMUS 2 45 0.001437 0.008194
817 NEGATIVE REGULATION OF DNA BINDING 2 46 0.001501 0.008508
818 REGULATION OF MYELOID CELL DIFFERENTIATION 3 183 0.001494 0.008508
819 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 2 46 0.001501 0.008508
820 REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH 2 46 0.001501 0.008508
821 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 2 46 0.001501 0.008508
822 REGULATION OF SECRETION 5 699 0.001527 0.008641
823 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 2 48 0.001633 0.009224
824 ANTERIOR POSTERIOR AXIS SPECIFICATION 2 48 0.001633 0.009224
825 REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 2 49 0.001702 0.009586
826 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 2 49 0.001702 0.009586
827 PROTEIN AUTOPHOSPHORYLATION 3 192 0.001715 0.009646
828 NEGATIVE REGULATION OF PHOSPHORYLATION 4 422 0.001739 0.009775
829 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 2 50 0.001771 0.009894
830 LYMPHOCYTE HOMEOSTASIS 2 50 0.001771 0.009894
831 REGULATION OF ADHERENS JUNCTION ORGANIZATION 2 50 0.001771 0.009894
832 RESPONSE TO PROGESTERONE 2 50 0.001771 0.009894
833 ENDODERM FORMATION 2 50 0.001771 0.009894
NumGOOverlapSizeP ValueAdj. P Value
1 CHROMATIN BINDING 9 435 1.505e-09 9.918e-07
2 MACROMOLECULAR COMPLEX BINDING 13 1399 2.135e-09 9.918e-07
3 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 12 1199 5.12e-09 1.585e-06
4 RECEPTOR BINDING 12 1476 5.253e-08 1.22e-05
5 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 5 90 8.161e-08 1.516e-05
6 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 7 328 1.116e-07 1.729e-05
7 TRANSCRIPTION FACTOR BINDING 8 524 1.537e-07 2.04e-05
8 SEQUENCE SPECIFIC DNA BINDING 10 1037 2.154e-07 2.501e-05
9 REGULATORY REGION NUCLEIC ACID BINDING 9 818 3.469e-07 3.223e-05
10 ENZYME BINDING 12 1737 3.154e-07 3.223e-05
11 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 4 50 4.205e-07 3.552e-05
12 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 8 629 6.166e-07 4.774e-05
13 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 6 315 2.003e-06 0.0001431
14 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 7 588 5.553e-06 0.0003685
15 KINASE BINDING 7 606 6.766e-06 0.0004191
16 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 5 226 7.788e-06 0.0004522
17 PROTEIN KINASE ACTIVITY 7 640 9.666e-06 0.0005282
18 PROTEIN HETERODIMERIZATION ACTIVITY 6 468 1.929e-05 0.0009957
19 DOUBLE STRANDED DNA BINDING 7 764 3.038e-05 0.001485
20 CORE PROMOTER BINDING 4 152 3.582e-05 0.001664
21 GROWTH FACTOR ACTIVITY 4 160 4.377e-05 0.001936
22 KINASE ACTIVITY 7 842 5.648e-05 0.002385
23 SMAD BINDING 3 72 9.72e-05 0.003926
24 BETA CATENIN BINDING 3 84 0.0001538 0.005067
25 C2H2 ZINC FINGER DOMAIN BINDING 2 14 0.0001353 0.005067
26 PROTEIN KINASE A CATALYTIC SUBUNIT BINDING 2 15 0.0001559 0.005067
27 OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR 2 15 0.0001559 0.005067
28 CYTOKINE ACTIVITY 4 219 0.0001477 0.005067
29 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 7 992 0.0001582 0.005067
30 RECEPTOR AGONIST ACTIVITY 2 16 0.0001781 0.005515
31 OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS 2 19 0.0002532 0.007588
32 DNA BINDING BENDING 2 20 0.0002811 0.008009
33 UBIQUITIN LIKE PROTEIN LIGASE BINDING 4 264 0.0003017 0.008009
34 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 3 105 0.0002973 0.008009
35 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 3 104 0.0002891 0.008009
36 CYTOKINE RECEPTOR BINDING 4 271 0.0003333 0.0086
37 IONOTROPIC GLUTAMATE RECEPTOR BINDING 2 23 0.0003735 0.00913
38 FIBROBLAST GROWTH FACTOR BINDING 2 23 0.0003735 0.00913
39 PROTEIN DIMERIZATION ACTIVITY 7 1149 0.0003904 0.0093
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR MATRIX 8 426 3.124e-08 1.695e-05
2 TRANSCRIPTION FACTOR COMPLEX 7 298 5.804e-08 1.695e-05
3 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 5 127 4.577e-07 8.91e-05
4 RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX 4 101 7.143e-06 0.001043
5 EXTRACELLULAR SPACE 9 1376 2.505e-05 0.002926
6 PLATELET ALPHA GRANULE LUMEN 3 55 4.336e-05 0.00422
7 PROTEINACEOUS EXTRACELLULAR MATRIX 5 356 6.885e-05 0.005744
8 WNT SIGNALOSOME 2 11 8.194e-05 0.005981
9 PLATELET ALPHA GRANULE 3 75 0.0001098 0.007123
10 BETA CATENIN DESTRUCTION COMPLEX 2 14 0.0001353 0.007899
11 SECRETORY GRANULE LUMEN 3 85 0.0001593 0.008455

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04390_Hippo_signaling_pathway 9 154 1.382e-13 2.488e-11
2 hsa04916_Melanogenesis 5 101 1.457e-07 1.312e-05
3 hsa04340_Hedgehog_signaling_pathway 4 56 6.673e-07 4.004e-05
4 hsa04310_Wnt_signaling_pathway 5 151 1.08e-06 4.859e-05
5 hsa04520_Adherens_junction 4 73 1.949e-06 7.018e-05
6 hsa04350_TGF.beta_signaling_pathway 3 85 0.0001593 0.004778
7 hsa04110_Cell_cycle 3 128 0.0005313 0.01366
8 hsa04330_Notch_signaling_pathway 2 47 0.001567 0.03525
9 hsa04510_Focal_adhesion 3 200 0.001926 0.03618
10 hsa04144_Endocytosis 3 203 0.00201 0.03618
11 hsa04010_MAPK_signaling_pathway 3 268 0.0044 0.072
12 hsa04151_PI3K_AKT_signaling_pathway 3 351 0.009258 0.1389
13 hsa04380_Osteoclast_differentiation 2 128 0.01107 0.1533
14 hsa04014_Ras_signaling_pathway 2 236 0.03481 0.4177

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1 RP11-12A2.3 hsa-miR-103a-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-30d-5p;hsa-miR-338-3p;hsa-miR-339-5p;hsa-miR-501-3p 12 TGFBR3 Sponge network -4.779 0 -1.535 0 0.524
2 LINC01018 hsa-miR-103a-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-335-3p;hsa-miR-338-3p;hsa-miR-423-5p;hsa-miR-589-3p 12 TGFBR3 Sponge network -3.231 0 -1.535 0 0.466
3 RP11-119D9.1 hsa-let-7d-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-182-5p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-335-3p;hsa-miR-338-3p;hsa-miR-501-3p 10 TGFBR3 Sponge network -2.765 0 -1.535 0 0.465
4 SNHG1 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-3p;hsa-miR-3607-3p;hsa-miR-497-5p 13 HMGA2 Sponge network 2.013 0 1.115 0.01594 0.448
5 RP11-216L13.19 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-497-5p 10 HMGA2 Sponge network 2.404 0 1.115 0.01594 0.383
6 RP11-498C9.15 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-5p;hsa-miR-33b-5p 12 HMGA2 Sponge network 1.487 0 1.115 0.01594 0.382
7 RP11-290F5.1 hsa-miR-103a-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-21-5p;hsa-miR-222-5p;hsa-miR-335-3p;hsa-miR-423-5p 10 TGFBR3 Sponge network -1.679 5.0E-5 -1.535 0 0.378
8 MAPKAPK5-AS1 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p 11 HMGA2 Sponge network 1.411 0 1.115 0.01594 0.376
9 SNHG12 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-33b-5p;hsa-miR-497-5p 12 HMGA2 Sponge network 1.791 0 1.115 0.01594 0.369
10 CTC-459F4.3 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3607-3p;hsa-miR-497-5p 12 HMGA2 Sponge network 1.207 0 1.115 0.01594 0.368
11 PTOV1-AS1 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30e-3p;hsa-miR-30e-5p 10 HMGA2 Sponge network 1.252 0 1.115 0.01594 0.365
12 RP11-479G22.8 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3607-3p;hsa-miR-497-5p 10 HMGA2 Sponge network 1.511 0 1.115 0.01594 0.36
13 GAS5 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-3p 10 HMGA2 Sponge network 1.966 0 1.115 0.01594 0.358
14 SNHG7 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-33b-5p;hsa-miR-497-5p 10 HMGA2 Sponge network 2.077 0 1.115 0.01594 0.355
15 RP11-89K21.1 hsa-let-7b-3p;hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-497-5p 10 HMGA2 Sponge network 4.915 0 1.115 0.01594 0.35
16 AP001469.9 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-3607-3p 12 HMGA2 Sponge network 2.428 0 1.115 0.01594 0.348
17 CTC-444N24.11 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30e-3p;hsa-miR-33b-5p;hsa-miR-3607-3p;hsa-miR-497-5p 12 HMGA2 Sponge network 1.087 0 1.115 0.01594 0.342
18 RP5-1074L1.4 hsa-let-7b-3p;hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-3607-3p;hsa-miR-497-5p 10 HMGA2 Sponge network 2.302 0 1.115 0.01594 0.333
19 SNHG11 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-3607-3p 12 HMGA2 Sponge network 1.239 0 1.115 0.01594 0.33
20 DYNLL1-AS1 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30e-3p;hsa-miR-33b-5p;hsa-miR-3607-3p 10 HMGA2 Sponge network 1.231 0 1.115 0.01594 0.328
21 LINC00665 hsa-let-7b-3p;hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-33b-5p;hsa-miR-3607-3p;hsa-miR-497-5p 12 HMGA2 Sponge network 2.394 0 1.115 0.01594 0.324
22 SNHG17 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-3607-3p;hsa-miR-497-5p 13 HMGA2 Sponge network 1.214 0 1.115 0.01594 0.317
23 TMCC1-AS1 hsa-let-7b-3p;hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-33b-5p;hsa-miR-3607-3p;hsa-miR-497-5p 12 HMGA2 Sponge network 2.298 0 1.115 0.01594 0.311
24 RP11-611E13.2 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3607-3p;hsa-miR-497-5p 11 HMGA2 Sponge network 1.148 0 1.115 0.01594 0.31
25 AC074117.10 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-497-5p 10 HMGA2 Sponge network 1.254 0 1.115 0.01594 0.309
26 RP1-228H13.5 hsa-let-7b-3p;hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-3607-3p 12 HMGA2 Sponge network 1.554 0 1.115 0.01594 0.309
27 RP11-435O5.2 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-33b-5p;hsa-miR-497-5p 11 HMGA2 Sponge network 2.087 0 1.115 0.01594 0.306
28 LINC00511 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-3607-3p;hsa-miR-497-5p 12 HMGA2 Sponge network 2.468 0 1.115 0.01594 0.3
29 AC005562.1 hsa-let-7b-3p;hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-33b-5p;hsa-miR-3607-3p;hsa-miR-497-5p 12 HMGA2 Sponge network 1.127 0 1.115 0.01594 0.3
30 WASIR2 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-3607-3p;hsa-miR-497-5p 10 HMGA2 Sponge network 3.623 0 1.115 0.01594 0.289
31 RP11-620J15.3 hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-3607-3p;hsa-miR-497-5p 11 HMGA2 Sponge network 2.159 0 1.115 0.01594 0.288
32 KB-1572G7.2 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-3607-3p;hsa-miR-497-5p 12 HMGA2 Sponge network 2.124 0 1.115 0.01594 0.286
33 RP11-540A21.2 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30e-5p;hsa-miR-3607-3p;hsa-miR-497-5p 11 HMGA2 Sponge network 1.758 0 1.115 0.01594 0.285
34 PXN-AS1 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-497-5p 11 HMGA2 Sponge network 1.561 0 1.115 0.01594 0.279
35 RP4-758J18.13 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-33b-5p;hsa-miR-3607-3p 10 HMGA2 Sponge network 1.374 0 1.115 0.01594 0.277
36 GUSBP11 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-3607-3p;hsa-miR-497-5p 13 HMGA2 Sponge network 2.066 0 1.115 0.01594 0.277
37 FLVCR1-AS1 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-33b-5p 11 HMGA2 Sponge network 2.147 0 1.115 0.01594 0.276
38 AC073283.4 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30e-3p;hsa-miR-33b-5p;hsa-miR-3607-3p;hsa-miR-497-5p 12 HMGA2 Sponge network 1.514 0 1.115 0.01594 0.275
39 RP11-392P7.6 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p 10 HMGA2 Sponge network 1.038 0 1.115 0.01594 0.274
40 CTD-3162L10.1 hsa-let-7b-3p;hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-5p;hsa-miR-3607-3p;hsa-miR-497-5p 10 HMGA2 Sponge network 3.111 0 1.115 0.01594 0.273
41 KCNQ1OT1 hsa-let-7b-3p;hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-3p;hsa-miR-33b-5p;hsa-miR-3607-3p 10 HMGA2 Sponge network 0.864 0 1.115 0.01594 0.27
42 CTD-3220F14.1 hsa-let-7b-3p;hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-5p;hsa-miR-3607-3p;hsa-miR-497-5p 11 HMGA2 Sponge network 3.223 0 1.115 0.01594 0.269
43 HCG18 hsa-let-7b-3p;hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-33b-5p;hsa-miR-3607-3p;hsa-miR-497-5p 13 HMGA2 Sponge network 1.42 0 1.115 0.01594 0.268
44 RP11-727A23.5 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-5p;hsa-miR-33b-5p;hsa-miR-3607-3p 12 HMGA2 Sponge network 1.435 0 1.115 0.01594 0.265
45 AC012146.7 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-33b-5p;hsa-miR-3607-3p;hsa-miR-497-5p 10 HMGA2 Sponge network 1.709 0 1.115 0.01594 0.259
46 STXBP5-AS1 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-33b-5p 10 HMGA2 Sponge network 1.715 0 1.115 0.01594 0.258
47 AC016747.3 hsa-let-7b-3p;hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30e-5p;hsa-miR-33b-5p;hsa-miR-3607-3p;hsa-miR-497-5p 12 HMGA2 Sponge network 1.235 0 1.115 0.01594 0.255
48 RP4-717I23.3 hsa-let-7b-3p;hsa-let-7c-5p;hsa-miR-125b-2-3p;hsa-miR-125b-5p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3607-3p 10 HMGA2 Sponge network 1.867 0 1.115 0.01594 0.25

Quest ID: 0ca4707ab98f4a9befaf9bca35e47635